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ABSTRACT 
 
James E. Ferguson, III: Investigating the Role of Ankyrin Repeat and  
SOCS Box Protein 4 (ASB4) During Vascular Development 
(Under the direction of Cam Patterson) 
 
The molecular mechanisms of endothelial differentiation into a functional vascular 
network are incompletely understood. To identify novel factors in endothelial development 
we employed a microarray screen using differentiating embryonic stem (ES) cells that 
identified Ankyrin Repeat and SOCS Box Protein 4 (ASB4) as the most highly differentially 
expressed gene in the vascular lineage during early differentiation. Like other SOCS box-
containing proteins, ASB4 acts as the substrate recognition molecule of an Elongin-
B/Elongin-C/Cullin/Roc ubiquitin ligase complex that mediates the ubiquitination and 
degradation of substrate protein(s). High levels of ASB4 expression in the embryonic 
vasculature coincide with drastic increases in oxygen tension as placental blood flow is 
initiated. However, as vessels mature and oxygen levels stabilize, ASB4 expression is 
quickly downregulated, suggesting that ASB4 may function to modulate an endothelial-
specific response to increasing oxygen tension. Consistent with the hypothesis that ASB4 
function is regulated by oxygen concentration, ASB4 directly interacts with Factor Inhibiting 
HIF1 (FIH), and is a substrate for FIH-mediated hydroxylation via an oxygen-dependent 
mechanism. Additionally, overexpression of ASB4 in ES cells promotes differentiation into 
iii
the vascular lineage in an oxygen-dependent manner. We propose that hydroxylation of 
ASB4 in normoxia promotes binding to and degradation of substrate protein(s) to modulate 
vascular differentiation.
iv
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Chapter 1 GENERAL INTRODUCTION 
A. ASB4 IS AN E3 UBIQUITIN LIGASE 
Ankyrin repeat and SOCS box protein 4 (ASB4) is a member of the Suppressor of 
Cytokine Signaling (SOCS) superfamily of proteins whose members all share a constant C-
terminal SOCS box domain, and variable N-terminal protein-protein interaction motifs (Fig. 
1-1A). The SOCS box has been shown to bind to an Elongin-B/Elongin-C/Cullin/Roc 
complex of proteins whose function as an E3 ubiquitin ligase has been well characterized 
(Fig. 1-1B). The N-terminal protein interaction motif binds to substrate protein(s) to 
optimally position them for ubiquitination and subsequent degradation. Thus, SOCS proteins 
are the substrate-receptors for an E3 ubiquitin ligase complex that controls steady-state levels 
of substrate proteins. Because of this, SOCS proteins like ASB4 are carefully regulated both 
at the transcriptional and post-translational level to tightly control substrate protein levels. 
Generally, polyubiquitin chain formation on proteins is a molecular signal for their 
proteasome-mediated degradation. Polyubiquitination is achieved through a cascade of 
biochemical reactions (Fig. 1-1B). First, E1 ubiquitin activating enzyme covalently binds to 
the 7 kDa ubiquitin protein via an ATP-dependent process. Next, the E1 enzyme transfers the 
ubiquitin to an E2 ubiquitin conjugating enzyme. Finally, in the case of cullin-containing 
complexes the E2 is closely approximated to the substrate by binding to the ring-finger 
domain of the E3 complex, which results in covalent attachment of ubiquitin to lysine 
residues of the substrate protein. This cycle is repeated and additional ubiquitin molecules are 
2added to the substrate-attached ubiquitin to produce a polyubiquitin chain. Ubiquitin chains 
longer than three molecules long are recognized by the proteasome and rapidly degraded. 
Ankyrin repeat and SOCS box proteins (ASBs) constitute one subclass of the SOCS 
superfamily and are characterized by variable numbers of N-terminal ankyrin repeats as 
substrate-binding domains (reviewed in 1). Over the past five years, at least 18 family 
members have been identified in mammals, and preliminary functional characterization is 
currently underway. So far, ASB proteins have been shown to mediate the ubiquitination of a 
broad range of target proteins including TNF receptor II (ASB3)2, Creatine Kinase B 
(ASB9)3, and Adaptor protein with PH and SH2 domains (APS) (ASB6)4. Since ankyrin 
repeats function as generic scaffolds creating modular binding sites that mediate interactions 
with an almost unlimited variety of binding motifs and domains,5, 6 it is not surprising that 
ASBs interact with and promote the degradation of a wide diversity of target substrate 
proteins. Thus, while these family members share the common function of ubiquitination and 
target protein degradation, the biologic ramifications of their activities are likely to be as 
diverse as the wide variety of substrates which they degrade. 
In order to identify novel and/or uncharacterized genes whose function is important to 
early vascular differentiation and development of the vascular lineage, we performed a 
microarray screen that identified genes that are highly differentially expressed in vascular 
cells (Flk1 positive cells) compared to non-vascular (Flk1 negative cells) during embryonic 
stem (ES) cell differentiation.7 Out of 20,000 genes, ASB4 was the most highly differentially 
expressed gene at early time points during differentiation into the vascular lineage.  This 
dissertation describes characterization of the involvement of the previously uncharacterized 
3gene ASB4 during vascular development, and more specifically, endothelial differentiation 
and maturation. 
B. BLOOD VESSEL DEVELOPMENT 
Endothelial Commitment (Vasculogenesis) is the first step in blood vessel 
development. Early in development, just after gastrulation, precursor cells of the vascular 
lineage differentiate from pluripotent mesoderm cells in response to inductive signals from 
neighboring endoderm.8, 9 These cells colocalize with hematopoietic precursors within the 
yolk-sac in structures called blood islands, raising the possibility that both lineages arise from 
a common precursor, the hemangioblast. Studies have indicated that both lineages bear 
certain common molecular markers, and cells with the potential to produce either lineage (as 
well as vascular smooth muscle cells (VSMCs) and cardiomyocytes, under specific 
conditions) have been isolated from differentiating mouse embryoid bodies.10, 11 However, it 
does not seem likely that hemangioblast identity is a required step for all endothelial 
development, and in fact direct differentiation of angioblasts from mesoderm is a well-
supported phenomenon.8, 12 In addition, it has been suggested that in some cases 
hematopoietic cells may arise directly from differentiated endothelium—so-called hemogenic 
endothelium.13, 14 Clearly, differentiation into the vascular and hematopoietic lineages during 
development is closely intertwined. 
Blood vessel formation is classically divided into two categories. Vasculogenesis 
refers to the in situ differentiation of endothelial cells to form blood vessels. In contrast, 
angiogenesis refers to the formation of new blood vessels via extension or remodeling of 
existing blood vessels. Angiogenesis occurs throughout development and in adulthood, 
4whereas vasculogenesis is generally thought to occur during a limited period early in 
embryonic development. Vasculogenesis is further subdivided based on whether it occurs 
within the extraembryonic or intraembryonic compartments. The best available evidence 
suggests that these two waves of vasculogenesis are temporally and spatially distinct, and 
molecular studies indicate that they are also partially distinct at the mechanistic level. 
Extraembryonic vasculogenesis precedes intraembryonic vascular development, and 
in mammals is first apparent as blood islands assembling within the mesodermal layer of the 
yolk sac. Blood islands are foci of hemangioblasts that differentiate in situ, forming a loose 
inner mass of embryonic hematopoietic precursors and an outer luminal layer of angioblasts. 
Blood islands eventually coalesce into a functional vascular network that constitutes the 
vitelline circulation, which is adapted to transfer nutrients from the yolk sac to the embryo 
proper. Recent evidence indicates that extraembryonic blood vessels may also arise 
independently of blood islands via direct differentiation of angioblasts from mesoderm.12 
Vessels arising via yolk sac vasculogenesis communicate with the fetal circulation via the 
vitelline vein, but otherwise do not contribute to intraembryonic vasculature. 
De novo extraembryonic vasculogenesis also occurs in the allantois, a structure 
responsible for the induction of placental development and for the formation of the umbilical 
vessels. Avascular allantoides can be excised from the developing embryo and cultured in 
isolation for one day, during which time they develop a definitive vascular plexus, indicating 
that vasculogenesis can proceed independently in the allantois during development.15, 16 
Because of this, primitive vessels are already in place in the allantois as it makes contact with 
the chorion to facilitate the formation of the maternal–fetal circulation. Whether these cells 
also contribute to hematopoiesis and whether they receive inductive signals from endoderm 
5or allantoic mesothelium is still undergoing debate, and may differ between species.17, 18 
Furthermore, given the close proximity of the developing allantois to the yolk sac mesoderm 
and posterior primitive streak,8 structures with potent hemangioblastic potential, further 
studies have sought to address the exact temporal and anatomic origins of the vasculogenic 
cells resident in the allantois.19 
Intraembryonic vasculogenesis. Recent evidence suggests that intraembryonic 
vasculogenesis can occur throughout most of the intraembryonic mesoderm, and much work 
has been done to characterize the different origins of particular vascular structures. As might 
be expected, the endocardium and great vessels are the first intraembryonic endothelial 
structures formed during development.12 The endocardium originates in mammals from 
clusters of migrating angioblasts derived from presomitic cranial mesoderm that enter the 
pericardial area to form a vascular plexus adjacent to the developing myocardium. This 
plexus then undergoes remodeling to form the endocardial tube. Simultaneous to heart 
development, vasculogenesis is initiated within the aortic primordia, a collection of 
mesoderm just lateral to the midline, to give rise to the dorsal aortae and the cardinal veins.20 
During this development, differentiating angioblasts assemble into primary vascular 
networks, which are then remodeled in a bidirectional fashion to generate the bilateral 
embryonic aortae. This region, later termed the para-aortic splanchnopleure (PAS), and then 
the aorta-gonad-mesonephros (AGM) region, continues to be a “hot-spot” for 
hematovascular differentiation during development.13 
As the heart enlarges, passive diffusion of nutrients and waste becomes limiting, and 
a coronary vasculature is formed to supply the metabolically active heart tissue. Vascular 
precursor cells (including endothelial and smooth muscle cell progenitors) reside in the pro-
6epicardium (PE)—a mass of cells that appears to originate from splanchnic mesoderm in 
conjunction with the septum transversum just inferior to the heart.21 This cell mass makes 
contact with the developing heart tube and quickly spreads over the entire heart. Once spread, 
these cells undergo epithelial-to-mesenchymal transformation and invade the underlying 
mesoderm to give rise to the capillaries, veins, and arteries of the coronary vasculature.22 The 
development of the coronary circulation is clearly unique, and still requires investigation to 
determine the timing and molecular nature of the signals necessary to induce endothelial 
differentiation in the PE.23, 24 
Capillary Plexi are Remodeled to Generate Mature Vasculature. Before blood flow 
can be established in the primitive vasculature, the capillary plexi of endothelial cells must be 
remodeled into a unidirectional circuit to allow proper blood circulation. To this end, 
endothelial cells are determined for either arterial or venous fate. Once this is accomplished, 
and simultaneous to blood flow initiation, VSMCs are recruited to surround the endothelial 
tubes and provide structural support and elasticity to the vessel wall. Once reinforced by this 
VSMC layer, the vasculature can develop in the midst of drastic increases in mechanical 
hemodynamic stresses during embryonic development. 
Once blood flow is established, the vasculature can be considered “mature” since it is 
exposed to the relatively constant environmental forces that will exist for the rest of the life 
of the organism (i.e. blood flow/shear stress, blood pressure/mechanical stress, blood 
oxygenation/oxygen stress, etc). However, when these environmental forces are perturbed, 
the vasculature can undergo a programmed response to correct the perturbation. Collectively, 
this response is termed “angiogenesis” and is thought to be largely mechanistically distinct 
from the process of “vasculogenesis” described above. During angiogenesis, new vessels 
7sprout from pre-existing vessels in response to signals from the surrounding tissues. Hypoxia 
is often the initial cue that sets this process in motion and can exist in many biologic 
situations. For example, tissues can develop hypoxia during periods of rapid growth as their 
metabolic demands exceed the supply of the inherent vasculature (as exhibited during 
embryonic development and tumorigenesis). Hypoxic tissues recruit new blood vessels by 
secreting growth factors that act specifically on vascular cells (described below), which leads 
to the breakdown of the vessel wall and concomitant migration/proliferation of endothelial 
cells towards the ischemic tissue. Once the endothelial circuit is re-established in the hypoxic 
tissue, oxygenation is increased, the hypoxic signal is abrogated, and the baseline vascular 
phenotype is resumed. Clearly, formation and maintenance of the vascular bed is a complex 
process that involves the coordinated actions of multiple cell types. However, the initial 
events of vascular development that involve endothelial differentiation, remodeling, and 
maturation, are the focus of this dissertation.  
C. GENETIC AND ENVIRONMENTAL FACTORS INFLUENCE VASCULOGENESIS 
The anatomic basis for vascular development in the embryo has been clarified 
through studies that have been performed over the past century. In contrast, the molecular 
underpinnings for endothelial cell differentiation have only become clear in the last twelve 
years. In addition to cell-autonomous genetic determinants of endothelial differentiation, 
soluble factors are released that influence the fate of multiple cell lineages. Gain and loss-of-
function studies have helped us identify some of the participants in vasculogenesis. 
Specifically, targeted gene inactivation studies have better-defined the molecular regulatory 
8mechanisms underlying these processes. In this section, the inter-relationships among some 
of the identified steps important to endothelial differentiation are reviewed. 
Initiation. Key to any inductive process in the embryo is the elaboration of signals 
that are integrated to mark the initiation of a developmental cascade. In the case of early 
events in endothelial differentiation, these cues must determine the spatial and temporal 
appearance of hemangioblasts from undifferentiated mesoderm, and also the further 
maturation and assembly of these precursors into nascent blood vessels. While our 
understanding of these processes is still growing, the best data indicate that crucial roles exist 
for members of the Fibroblast Growth Factors (FGF) and Bone Morphogenetic Proteins 
(BMP) growth factor families as proximal inductive cues for the hematovascular lineage. 
Definitive endoderm and mesoderm specification is also thought to be mediated in part by 
Brachyury, a transcriptional target of the Wnt signaling pathway.25 However, little is known 
about how these upstream factors interact to specify vascular identity of precursors and none 
of these signals has specificity for the vascular lineage. 
The first secreted molecule with specificity for the endothelium during development 
is Vascular Endothelial Growth Factor (VEGF), and the role of VEGF family members in 
developmental and adult angiogenesis is now well-described. Mice lacking a single copy of 
the VEGF gene die early in development due to vascular defects, indicating that only slight 
perturbations of this signaling pathway can disrupt vascular development.26 Since cells that 
respond to VEGF must first express its receptors (Flk1/VEGFR2 and Flt1/VEGFR1), VEGF 
itself cannot be the most proximal signal for endothelial differentiation. 
VEGF/Flk1 Regulation. Several upstream factors have been shown to regulate VEGF 
and Flk1 expression. The transcription factor Hypoxia Inducible Factor-1 (HIF-1) and its 
9family members play crucial roles in sensing changes in tissue oxygen tension and in 
stimulating gene expression changes that enhance blood vessel growth into hypoxic tissues 
during post-gastrulation development27 (described in next section). Evidence supports BMP 
signaling as a proximal stimulus for Flk1 expression, and at the transcriptional level there 
appears to be necessary roles for GATA family proteins as well as the homeodomain protein 
HoxB5 in upregulation of Flk1 during development.28 Another layer of regulation in 
endothelial development is ascribed to the ETS family of transcriptional factors that direct 
downstream endothelial specific expression of Flk1, Flt1, the angiopoietin receptors, and 
MEF2C, a recently identified member of the MADS box superfamily of vascular 
developmental transcription factors.29 A genetic mutation of an unknown gene, termed 
“cloche,” leads to Flk1 deficiency with a subsequent failure in vasculogenesis.30, 31 Further 
studies are needed to identify and characterize upstream cues that initiate Flk1 expression 
and concomitant endothelial differentiation. 
Functional Markers of Endothelial Differentiation. Identified markers of endothelial 
cells are used to track their transition from the early stages of stem cell differentiation to the 
mature vessel, as well as to distinguish them from other lineages, such as hematopoietic and 
smooth muscle. Not surprisingly, many of the molecules used to track endothelial identity are 
also functionally important. The appearance of Flk1 expression is at the present time the 
earliest marker available for the endothelial lineage during development.32, 33 Flk1 is 
expressed in early endothelial and hematopoietic precursor cells, but persists only in mature 
endothelium but not mature hematopoietic lineages. This pattern suggests that Flk1 may be a 
marker for hemangioblasts during early development, and this is born out by studies that 
indicate that the co-expression of Flk1 with mesoderm-derived transcription factors 
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Brachyury or Scl/Tal denotes hemangioblasts.12, 34 As the endothelial lineage progresses, the 
expression of Brachyury followed by Scl/Tal are lost, whereas the Flk1 marker is retained.35 
Notably, flk1-/- mice are embryonic lethal due to drastically reduced levels of vascular 
precursors and failure in blood vessel formation, while elimination of SCL/Tal expression 
arrests hematopoiesis, but allows for endothelial cell progression.36 The entire transcriptional 
program of the endothelial lineage is yet to be established, and this represents a major 
limitation in our understanding of how cell-autonomous mechanisms coordinate development 
of vascular cell lineages. 
Combinations of endothelial-specific markers including VE-cadherin, PECAM-1, 
Tie-1, Tie-2, Flk1, and Flt1 are commonly used to trace endothelial differentiation. As might 
be expected, these markers also serve in functions vital to endothelial formation, remodeling, 
and maintenance. For example, VE-cadherin is expressed from the committed angioblast to 
the mature endothelial cell, but not in hematopoietic progenitor cells. VE-cadherin, an 
adhesive cell–cell recognition protein, participates in cell-migration during vascular 
morphogenesis. With the ability to anchor to the cortical actin cytoskeleton via catenin 
proteins and vinculin, VE-cadherin offers junctional strength between endothelial cells. Mice 
deficient for VE-cadherin fail to couple a VEGF–dependent endothelial survival signal to -
catenin and PI3-K, resulting in early embryonic death caused by severe vascular defects.37 
PECAM-1 and Tie also function during endothelial differentiation with roles in adhesion and 
vascular network formation, respectively.38 PECAM-1 is commonly used to trace endothelial 
morphological development (i.e. sprouting vessels).28, 39 Although the fine points of their 
signal transduction pathways remain poorly understood, the function of markers used to 
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identify endothelial cells and their progenitors have provided us a framework for reaching a 
more complete understanding of vasculogenesis. 
Additional Regulatory Cues. Downstream of the early events, the cues required for 
blood vessel assembly become better known, if also more complex. Among paracrine factors, 
the Angiopoietin family members bind to the tyrosine kinase receptors Tie-1 and Tie-2, 
which play crucial roles in endothelial cell survival and remodeling of capillary plexi.40 
Several transcription factors are known to participate in vascular assembly including 
Vascular Endothelial Zinc Finger, GATA proteins, several members of the Kruppel-like 
family of zinc finger proteins, and Ets proteins.41, 42 Finally, Platelet-derived Growth Factors 
(PDGFs) are required for recruitment of pericytes and VSMCs to invest developing arteries 
and establish vasomotor tone.43 Obviously, blood vessel formation requires multiple 
pathways that talk among one another to coordinate the spatial and temporal differential gene 
expression pattern during blood vessel formation. 
Vessel Fate. Interestingly, the fate of arterial, venous, and lymphatic vessels are in 
part genetically determined early during vascular development before circulation and during 
the amalgamation of blood islands in the yolk sac. Molecules such as Ephrins, Ephrin 
Receptors, neuropilin receptors, and type-A plexins serve as markers for arterial and venous 
identity, and appear well before the structuring of tube-like vessels.44 Arterial cell fate 
appears to be determined by intersecting signaling cascades involving first sonic hedgehog 
(Shh), then VEGF, followed by the Notch pathway.45 Loss of Shh or VEGF results in loss of 
arterial markers, whereas VEGF can rescue arterial differentiation in the absence of Shh 
signaling. The Notch pathway has also been reported to repress venous markers and to 
promote the expression of artery-specific genes.46 Ephrins and their tyrosine kinase receptors 
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(Ephs) are required for arterio-venous communications.47 Ephrin-B2, a membrane bound 
ligand with specificity toward the Eph-B4 receptor, marks arterial but not venous endothelial 
cells from the onset of vessel remodeling. In turn, Eph-B4 marks veins but not arteries.48 The 
null phenotype for each of these genes is similar, suggesting reciprocal coordination between 
these molecules in the formation of capillary beds. 
Environmental Factors. Clearly, genetics plays a crucial role in determining vascular 
development, especially in early stages such as endothelial specification and capillary plexus 
formation. However, the embryo doesn’t develop in a vacuum. Rather, the developing 
embryo and its vasculature undergo drastic environmental changes that impact the 
development of the vasculature in fundamental ways (Fig. 1-2). First, following the initiation 
of the heart beat and completion of cardiac valvulogenesis, blood flow is initiated and both 
blood flow and blood pressure rise sharply. The endothelium is exposed to these changes and 
transduces a signal requiring KLF2 to remodel appropriately to these cues.49 Second, shortly 
after the initiation of blood flow, the vasculature of the placenta forms and embryonic 
erythrocytes are juxtaposed to maternal blood for the first time. As maternal-fetal blood gas 
exchange proceeds, the oxygen levels of the developing embryo increase rapidly from 
hypoxia to relative normoxia, and all cells must transduce these environmental signals into 
appropriate developmental responses (discussed in next section). 
Both the sudden increase in hemodynamics and the increase in blood gas oxygen 
levels are environmental cues that influence endothelial development around the remodeling 
stage. Perhaps these signals help to specify arterial/venous fate, and/or instruct the 
strengthening of major vessels (through VSMC recruitment) and the regression of minor 
13
vessels.50 Experiments to address these issues will require sophisticated models and 
approaches such as those described in Chapters 2 and 3. 
D. MECHANISMS OF OXYGEN SENSING IN THE VASCULAR LINEAGE 
While it is well accepted that hypoxia drives angiogenesis in the adult vasculature, 
comparatively little is known about the behavior of the endothelium in the hypoxic 
environment of the early embryo, and how it responds to the drastic change in oxygen 
tensions following functional development of the placenta.  
Cell-specific Oxygen Responses. The hypoxic response of cells of the vascular lineage 
is unique. Most non-vascular cells respond to hypoxia by switching to anaerobic respiration, 
blunting highly energetic processes such as protein translation and cell division, and halting 
differentiation.51, 52 In addition, they secrete growth factors such as VEGF and Erythropoeitin 
(Epo) that act to re-establish perfusion and oxygenation, respectively. Each of these 
responses is mediated in large part by HIF transcription factors (described below). In 
contrast, in order to revascularize ischemic tissue, the cells of the vascular lineage must be 
able to undergo extensive morphologic and phenotypic changes such as migration, 
proliferation, and/or differentiation in the face of this hypoxic environment. Various data 
support this unique response of the vascular lineage to hypoxia, but the mechanisms behind 
this unique response, and the hypoxic response in general are limited.53 Notably, HIF1 is 
nearly ubiquitously expressed, and therefore cannot account for this endothelial-specific 
responses to hypoxia. 
Hypoxia Inducible Factor. The current understanding of the cellular response to 
oxygen tension centers around the Hypoxia Inducible Factor (HIF) family of transcription 
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factors whose steady-state levels and activity vary inversely with oxygen concentration 
(reviewed in 51, 54, 55). HIF transcription factors are heterodimeric complexes composed of an 
-subunit and a -subunit. So far, 3 -subunit genes and 3 -subunit genes have been 
identified in eukaryotes. While -subunits are nearly ubiquitously expressed at the protein 
level, -subunits are constitutively transcribed and translated, but protein levels are tightly 
suppressed via post-translational modifications under normoxic conditions. This suppression 
(described below) is released under hypoxic conditions, allowing HIF dimerization and 
transcriptional activation. Once active, HIF heterodimers bind to hypoxia response elements 
(HREs) in the promoters of hypoxia responsive genes. These genes, in turn, are important for 
the hypoxic response of the whole organism, tissues, and individual cells. For example, in the 
face of global whole-animal hypoxia such as that found at high altitude, HIF induces the 
transcription of EPO which stimulates red blood cell formation and the oxygen-carrying 
capacity of the blood. In order to increase the oxygenation of ischemic tissues, HIF induces 
the transcription of a variety of angiogenic genes. Hypoxic stromal cells upregulate the HIF-
dependent transcription and secretion of VEGF and FGF isoforms which act to stimulate the 
migration of endothelial cells into the hypoxic tissue. Furthermore, transcription of VEGF 
receptors Flk1 and Flt1 is activated in endothelial cells by HIF, further sensitizing them to the 
VEGF stimulation under hypoxic conditions. All of these signals function to revascularize 
the ischemic tissue, resulting in tissue reperfusion and return to normoxia. Finally, HIF 
activity orchestrates the immediate response of cells to hypoxia by allowing a short-term 
shift to oxygen-independent cellular metabolism. A variety of genes important in anaerobic 
respiration are upregulated to allow energy production in spite of decreased oxygen-
dependent oxidative phosphorylation. These genes include glucose transporters such as Glut-
15
1), Phosphoglycerate Kinase (PGK1), and Lactate Dehydrogenase (LDH). HIF clearly plays 
an important role at all levels of the hypoxic response. 
Mouse genetic models have shed considerable insight into the biologic importance of 
HIF family members during vascular development. HIF1-/- mice die by day 11 of gestation 
due to extensive vascular defects and cardiovascular malformation.56, 57 Vasculogenesis 
occurs normally in these mice, but the vascular endothelium fails to remodel properly and 
regresses by day 9.5.  
HIF2-/- mice have been generated by three separate groups with different results.58-60 
In the first group, HIF2-/- mice died in mid-gestation due to bradycardia secondary to 
decreased catecholamine synthesis.60 In the second group, some mice survived until birth, but 
died in the first day due to respiratory distress syndrome secondary to defects in lung 
surfactant production.58 Finally, a third group also observed bradycardia with lethality 
between day 9.5 and day 13.5 that was accompanied by extensive defects in both 
intraembryonic and extraembryonic vascular remodeling.59 Like the HIF1-/- embryos, these 
animals exhibit normal vasculogenesis, but fail to normally remodel the capillary plexus, 
which produces improper vascular connections and results in vascular hemorrhage and pre-
natal mortality.  
Mice deficient for HIF1/ARNT die by day 10.5 of embryonic development due to 
defective vascularization of the yolk sac, branchial arches, and placenta.61-63 Again, similar to 
mice lacking HIF subunits, initial development of the vascular beds proceeds normally, but 
vessel remodeling is abnormal. Taken together, these data support the hypothesis that HIF 
family members are crucial for proper vascular remodeling during embryonic development. 
Since remodeling of the primary capillary plexus into a mature vascular network occurs 
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during rapid changes in embryonic oxygen tension, it is intriguing to speculate that HIF 
family members are necessary for transducing environmental oxygen cues into appropriate 
vascular biologic responses and that this process is critical for proper vascular remodeling 
and maturation. 
HIF Regulation. The mechanisms of oxygen sensing by the cell and by the HIF 
pathway specifically have been rigorously studied over the past eight years. While various 
organelles have been implicated as oxygen sensors, including mitochondria and endoplasmic 
reticulum, the exact mechanisms are still elusive.64 On the other hand, the mechanisms of 
oxygen sensing by the HIF pathway are better understood (Fig. 1-3). HIF subunits are 
hydroxylated on asparagine and proline residues by Factor Inhibiting HIF1 (FIH) and the 
Prolyl Hydroxylase enzymes (PHDs), respectively. These hydroxylation reactions are 
dependent upon oxygen concentration, and the KD of these enzymes for oxygen lies in the 
range of physiologic oxygen concentrations. In this way, slight perturbations of oxygen 
concentrations result in drastic changes in enzymatic activity. Thus, these hydroxylase 
enzymes directly transduce oxygen environmental cues into biochemical signals: i.e. they act 
as biologic oxygen sensors. FIH-mediated HIF hydroxylation disrupts binding to the 
transcriptional co-activator p300 and results in decreased transcriptional activity, whereas 
PHD hydroxylation promotes binding of von Hippel Lindau (VHL) protein, a SOCS protein 
that mediates HIF polyubiquitination and proteasomal degradation through an Elongin-
B/Elongin-C/Cul2/Roc1 complex. Since these hydroxylation reactions are oxygen-
dependent, decreases in oxygen concentration (hypoxia) result in: 1) disruption of VHL 
binding to and degradation of HIF, leading to accumulation of HIF levels, and 2) promotion 
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of p300 binding, leading to an increase in HIF transcriptional activity. By these mechanisms, 
HIF is, according to its name, induced by hypoxia. 
In conclusion, the oxygen-dependent effects of hydroxylase enzymes on HIF activity 
suggest that they act as cellular “oxygen sensors” that are important in the transduction of 
environmental hypoxic cues into appropriate cellular signals such as HIF-mediated 
upregulation of glycolytic and angiogenic genes. Nevertheless, the list of bona fide 
hydroxylation targets of FIH and the PHDs is limited. In fact, until recently, HIF family 
members were the only known FIH and PHD substrates, and also the only identified 
cytosolic hydroxylated proteins. (Collagen and epidermal growth factor domain-containing 
proteins are extracellular hydroxylated proteins).65 Thus, a major goal in the field has been to 
identify novel hydroxylation substrates in order to improve our understanding of the cellular 
response to changing oxygen tensions. Herein, I describe the endothelial-specific expression 
of ASB4, an FIH hydroxylation substrate that may provide a mechanistic explanation for the 
endothelial-specific response to hypoxia during development. 
E. EMBRYONIC STEM CELLS AS A MODEL SYSTEM FOR VASCULOGENESIS 
Embryonic stem (ES) cells, especially those of murine origin, have revolutionized our 
ability to investigate the process of blood vessel development. They have been used to study 
not only the earliest stages of endothelial specification,10, 11, 28, 66 but also later morphogenetic 
processes in the primitive vasculature.39 In fact, vascular differentiation in the embryoid body 
(EB) system so closely recapitulates that of early in vivo vascular development that it has 
been suggested that vascular phenotypes of genetic mutant animals can be predicted from the 
vascular phenotypes of their cognate ES cells in culture.67-69 Furthermore, the accessibility of 
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this system has allowed genome-wide gene-trap analyses to identify novel genes whose 
expression is confined to the developing vasculature.70 In addition to the EB model of ES cell 
differentiation, ES cells cultured under tightly defined conditions to promote the growth of 
specific lineages have been used to support and study the role of lineage-specific precursors, 
especially hemangioblasts, during development.10 In fact, these same culture conditions have 
recently been used to determine that cells with potential to differentiate into both blood and 
endothelial cells exist in the posterior primitive streak of the early mouse embryo.34 It is clear 
that the culture conditions (media, coated dishes, feeder cells, cystic embryoid body 
formation, etc.) play important roles not only in the kinetics but also in the extent of 
endothelial differentiation in these systems. It is also important to note that these stem cell 
systems are devoid of blood flow and lack the spatial organization and unique environmental 
conditions of the developing embryo, perhaps limiting their usefulness as physiologically 
relevant models for later developmental programs which exhibit greater degrees of cellular 
and environmental complexity. However, earlier processes such as vascular lineage 
specification, endothelial differentiation, and capillary plexus formation faithfully mimic the 
in vivo processes and ES cells can be cultured under hypoxic conditions to evaluate the 
effects of oxygen concentration on these biologic processes. 
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Figure 1-1 ASB4 Ubiquitin ligase complex.  
(A) ASB4 structural schematic. ASB4’s domain architecture consists of an N-terminal variable region (NTV), 9 
tandem ankyrin repeats (AR) (poorly conserved ARs are denoted by parentheses), and a C-terminal SOCS box.  
 
(B) Like other SOCS proteins, ASB4 binds an Elongin-B/Elongin-C/Cullin/Ring complex through its SOCS 
box, which contacts with both Elongins and Cullin. In this way, ASB4 confers substrate-specificity to the E3 
ubiquitin ligase complex, mediating ubiquitination and subsequent degradation of substrate proteins.  S, SOCS 
box.  BC, elongins B/C.  Cul, cullin.  Ring, ring finger protein (also referred to as Roc).  E2, ubiquitin 
conjugating enzyme.  E1, ubiqutin activating enzyme.  Ub, ubiquitin. 
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Figure 1-2 Endothelial development. 
Early endothelial differentiation occurs under relatively constant environmental conditions, however later 
cardiovascular development including endothelial capillary plexus formation, and vascular sprouting and 
remodeling, occur alongside drastic changes in both blood flow (sensed by the endothelium in the form of shear 
stress), and oxygen levels. Shear stress increases drastically around day 8.5 as the heart tube begins to contract 
and endocardial cushions are remodeled into heart valves. Oxygen levels increase drastically around day 9.5 as 
the placental vasculature develops and maternal-fetal blood gas exchange is established. Notably, ASB4 is 
expressed in the endothelium during drastic changes in oxygen levels, suggesting that it might play a role in the 
response of the endothelium to changing oxygen tension. 
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Figure 1-3 HIF schematic. 
Under normoxic conditions, HIF1 subunits are hydroxylated on asparagine (N) and proline (P) residues by 
FIH and PHD enzymes, respectively. Asparagine hydroxylation prevents binding with the transcriptional co-
activator p300, while proline hydroxylation promotes binding with the E3 ligase VHL, resulting in HIF1
degradation. Under hypoxic conditions, both hydroxylases are inhibited, HIF1 is stabilized and available for 
complex formation with HIF1 and p300. These complexes bind to hypoxia response elements (HRE) in the 
promoters of various hypoxia response genes to initiate the hypoxic response.
Chapter 2 ASB4 IS A HYDROXYLATION SUBSTRATE OF FIH AND PROMOTES 
VASCULAR DIFFERENTIATION VIA AN OXYGEN-DEPENDENT MECHANISM 
A. INTRODUCTION 
Protein members of the suppressor of cytokine signaling (SOCS) superfamily are E3 
ubiquitin ligase components that contain a C-terminal SOCS box and an N-terminal protein-
protein binding domain.71,72 The SOCS box mediates interactions with an Elongin-
B/Elongin-C/Cullin/Roc protein complex to constitute a functional E3 ubiquitin ligase 
complex,73 while the N-terminal protein-protein binding domains recruit substrate proteins to 
mediate substrate polyubiquitination and proteasome-mediated degradation. In this way, 
SOCS proteins confer substrate specificity to the E3 ubiquitin ligase complex and are thus 
tightly regulated at both the transcriptional and post-translational levels in order to carefully 
control the steady state levels of substrate proteins.  
Ankyrin repeat and SOCS box proteins (ASBs) constitute one subclass of the SOCS 
superfamily and are characterized by variable numbers of N-terminal ankyrin repeats as 
substrate-binding domains (reviewed in 1). To date, at least 18 family members have been 
identified in mammals, and preliminary functional characterization is currently underway. So 
far, ASB proteins have been suggested to mediate the ubiquitination of a broad range of 
target proteins including TNF receptor II (ASB3)2, Creatine Kinase B (ASB9)3, and APS 
(ASB6)4. Since ankyrin repeats function as generic scaffolds creating modular binding sites 
that mediate interactions with an almost unlimited variety of binding motifs and domains,5, 6 
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it is not surprising that ASBs interact with and promote the degradation of a wide diversity of 
target substrate proteins.  
Our previous data indicate that ASB4, a poorly characterized member of this family, 
is highly differentially expressed in the vascular lineage during development.7
Vasculogenesis, or the de novo differentiation of pluripotent stem cells into the vascular 
lineage during development, is the first stage of blood vessel formation. Vasculogenesis 
begins shortly after gastrulation in the developing embryo, as cells with vasculogenic 
potential have been isolated from the primitive streak region in E6.5 mouse embryos.34 These 
cells, termed hemangioblasts, derive from mesoderm, express Brachyury (T) and Flk1, and 
have both vascular and hematopoietic potential. Primitive capillary plexi of endothelial cells 
arise from these populations, and are then remodeled in a process similar to adult 
angiogenesis to yield mature lumenized vessels.  
A complex combination of genetically pre-programmed molecular signals and 
external environmental cues are responsible for proper vascular development and 
remodeling, and an important role of oxygen tension in these processes has recently been 
discovered. The current understanding of the cellular response to oxygen tension centers 
around the Hypoxia Inducible Factor (HIF) family of transcription factors whose steady-state 
levels and activity vary inversely with oxygen concentration (reviewed in 51, 54, 55). Factor 
Inhibiting HIF1 (FIH) and the Prolyl Hydroxylase enzymes (PHDs) catalyze the 
hydroxylation of HIF on asparagine and proline residues, respectively. FIH-mediated HIF 
hydroxylation disrupts binding to the transcriptional co-activator p300 and results in 
decreased transcriptional activity, whereas PHD hydroxylation promotes binding of von 
Hippel Lindau (VHL) protein, a SOCS protein that mediates HIF polyubiquitination and 
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proteasomal degradation. Since atmospheric oxygen is utilized in these hydroxylation 
reactions, decreases in oxygen concentration (hypoxia) result in: 1) disruption of VHL 
binding to and degradation of HIF, leading to accumulation of HIF levels, and 2) promotion 
of p300 binding, leading to an increase in HIF transcriptional activity. 
Because of its effects on HIF activity, FIH is considered, along with the PHDs, to be 
a cellular “oxygen sensor” that is central to the transduction of environmental hypoxic cues 
into appropriate cellular signals such as HIF-mediated upregulation of glycolytic and 
angiogenic genes. Nevertheless, the list of bona fide hydroxylation targets of FIH is limited. 
In the present report, we demonstrate that ASB4 is expressed during vascular development in 
a window of time during which oxygen tensions are rapidly changing, is a direct target for 
FIH-dependent hydroxylation, and promotes differentiation into the vascular lineage in an 
oxygen-dependent manner. 
B. MATERIALS AND METHODS 
Plasmids— Flag-tagged mouse ASB4 in pEF1 and flag-tagged mouse ASB1 in pEF1 
were generous gifts from W. Alexander. All PCR amplimers for cloning were TA-cloned, 
sequenced for accuracy, and (unless otherwise noted) subcloned into destination vectors as 
N-terminally tagged mouse sequences. All amino acid locations refer to accession 
#NP_075535. Myc-ASB4 was generated by PCR amplification using flag-ASB4 in pEF1 as 
a template and the primer pair: F: 5’ ggatccttggacggcatcactgcccctatc, R: 5’ 
gaattcttagtaaatgattccctctggctc, and subcloned into BamHI/EcoRI sites in pCMV3B. 
3xflagASB4 in pCMV was generated by inserting a PCR amplimer using the following 
primers into EcoRI/BamHI digested p3xflag-CMV10 (Sigma): F: 
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5’gaattcagacggcatcactgcccctatc, R: 5’ggatccttagtaaatgattccctctggctc. The following flag-
tagged constructs were amplified using flag-ASB4 in pEF1 as template with the following 
primers before sucloning into BamHI/EcoRI sites in pCMV2B (stratagene). Flag-ASB4 
primers: F: 5’ctgggatccgacggcatcactgcccctatc, R: 5’ gaattcttagtaaatgattccctctggctc. Flag-
ASB4SOCS primers: F: 5’ctgggatccgacggcatcactgcccctatc, R: 
5’ctggaattcttatctgggggtgttgcagcacac. Flag-ASB4AR1 primers: F: 
5’ctgggatcctgggccacaggcctgcatctg, R: 5’ gaattcttagtaaatgattccctctggctc. Flag-ASB4AR1-7 
primers: F: 5’ctgggatccgacggcatcactgcccctatc, R: 5’ctggaattcttacagcacgtactggatagcggcaca. 
Flag-ASB4AR4-9 primers: F: 5’ctgggatccgggcacactgctttgcacttc, R: 
5’ctggaattcttatctgggggtgttgcagcacac. Deletion mutants and point mutants were generated 
using the Quickchange mutagenesis kit (Stratagene) using flag-ASB4 in pCMV as a template 
with the following primers (since primers are reverse complements of each other, only one 
primer per pair is listed here): Flag-ASB4AR4: 
5’tactccctgagcgggcacacacccctgcacacggcagc. Flag-ASB4AR5: 
5’ccaacaaccaggatgaagagaccccactggccattgccacc. Flag-ASB4AR6: 
5’gcatgaacgcccacatggagaagtcccctctacac. Flag-ASB4AR7: 
5’cgctcgtgatgatgacttcaagacctccgtgcgtcctgctgc.  
Human FIH was amplified from a yeast 2-hybrid prey clone described below using 
the following primers (F: 5’ggatccgcggcgacagcggcggaggctgtggcctctggctctg, R: 
5’gaattcctagttgtatcggcccttgatcattg), digested with BamHI/EcoRI, and subcloned into 
pCMV3B (stratagene) to generate a myc-FIH mammalian expression construct.  
An ASB4SOCS fragment for use as a fusion bait protein in yeast 2-hybrid assays 
was amplified from flag-ASB4 in pEF1 template using the following primers (F: 5’ 
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tatccatggtggacggcatcactgcccctatc, R: 5’ ctgggatccttaatcccagtgtttctccaagtc), and was 
subcloned into pGBKT7 vector (Clontech) using NcoI-BamHI insertion sites. pGBKT7, 
pGADT7, pGBKT7-p53, and pGADT7-T were from Clontech. 
To generate flag-ASB4 and flag-ASB4SOCS encoding adenoviruses, inserts flanked 
by XbaI sites were excised with XbaI and subcloned into pAdTrack-CMV for adenoviral 
production. All adenoviruses co-expressed CMV promoter-driven GFP. 
Reagents— MG-132 was dissolved in DMSO at a stock concentration of 20mM and 
diluted to 40µ for use in experiments. Equal volumes of DMSO alone were used in all 
conditions not treated with MG-132. Dipyridyl, CoCl2, and dimethyloxaloylglycine (DMOG) 
were obtained from Sigma dissolved sterile water. G418 (Gibco). 
Antibodies— anti-FIH (Novus #NB 100-428). Anti-flag (Sigma), anti-myc (Santa 
Cruz, #sc-789), anti flag beads (Sigma #A2220), anti myc beads (Santa Cruz), cul2 (Xiong 
raised against: RSQASADEYSYVA)74, cul5 (Xiong raised against SNLLKNKGSLQFEDK), 
elongin B (Santa Cruz #sc-1558), Roc1 has been described previously74, anti-ub (Covance 
#MMS-258R).  
Cell culture and Transfection Conditions— ES cell culture, differentiation, and FACS 
analysis have been described previously.75 Hypoxia culture was performed at 1% O2 and 5% 
CO2. HEK-293T cells were used in all transfection experiments. Unless otherwise noted, 
cells were transfected using Fugene 6 transfection reagent (Roche). Generally, 9µg DNA, 27 
µl F6 per 10cm dish. Cells were incubated for 24 hrs before lysis. For generation of ASB4 
overexpressing stable ES cells, 3X-flag ASB4 in p3xflag-CMV 10 (Sigma) was linearized 
and electroporated into R1 ES cells. Stable expressors were selected for with 250 µg/ml 
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G418 for 14 days. Positive clones were picked, amplified, and confirmed by anti-flag 
immunoblot. COS7 cells were used for adenoviral infection. 
Microarray analysis— Purification and amplification of mRNA from ES cells, 
reverse transcription, and microarray techniques have been described previously.7 For this 
analysis, the data set was subjected to supervised hierarchical clustering using only genes 
demonstrating O1.5 fold absolute Mean Fold Difference (MFD) in 84 h flk1+ cells from 
embryoid bodies. Median centered genes and arrays were clustered with Cluster (Version 
2.11, http://rana.lbl.gov/EisenSoftware.htm) and heatmaps of cluster analyses were 
visualized with JavaTreeView (Version 1.0.12, release date 2005-3-14; 
http://sourceforge.net/projects/jtreeview/). 
RT-PCR analysis—Briefly, total RNA was isolated using RNeasy kits (Qiagen). On-
column DNase treatment was performed to prevent genomic DNA contamination. For semi-
quantitative RT-PCR analysis, 2 µg of total RNA was reverse transcribed with SuperScript II 
RT (invitrogen) using oligo dT primers. One tenth of RT reaction volume was used as 
template for PCR analysis. ASB4 primers: F: 5’gagacacccctgcacacggcag, R: 
5’ctcaggctgtgcagcaggacgc. GAPDH primers were: F: 5’accacagtccatgccatcac, R: 
5’tccaccaccctgttgctgta.  
For real-time PCR analysis, 250 ng of total RNA was reverse transcribed using 
iScript kit (Biorad) using a mixture of oligo dT and random hexamer primers. The reaction 
was diluted 1:10, and 2.5 µl of the resulting mixture was used as a template in 12.5 µl
reactions for real-time PCR reactions performed using the ABI PRISM® 7900 sequence 
detection system, software, and reagents. The following pre-validated primer and probe sets 
based on Taqman® chemistry (Applied Biosystems) were used: flk1 mM01222419_m1, 
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PECAM: mM00476702_m1, VE-cadherin: Mm00486938_m1, tie2: mM01256892_m1, 
gata1: Mm00484678_m1, klf1: Mm00516096_m1, scl/tal: Mm00441665_m1, brachyury: 
Mm00436877_m1. Triplicate reactions from independent RNA samples were performed. 
RNA input was calibrated with 18S expression levels and relative mRNA levels were 
normalized to wild-type undifferentiated ES cells. 
Whole-mount in situ hybridization— Whole mount in situ hybridization on mouse 
embryos has been previously described.75 A 900bp template for ASB4 probe preparation was 
prepared using the primers (F: 5’tatccatggtggacggcatcactgcccctatc, R: 
5’ctcaggctgtgcagcaggacgc) and TA cloned in pCRII topo vector (invitrogen). Digoxigenin 
labeled single-strand sense and antisense RNA probes were prepared using the DIG RNA 
labeling kit (Roche). Embryos were isolated from pregnant CD-1 mice from E6.5 to E11.5, 
fixed with 4% paraformaldehyde (PFA) in PBS with 0.1% tween-20 (PBT), dehydrated in an 
increasing methanol series, and rehydrated in a decreasing methanol series in PBT. Embryos 
were treated with 6% H2O2 for 1 hr, washed, treated with 10µg/ml Proteinase K for 5 mins, 
washed with 2mg/ml glycine, refixed for 20 mins in 0.2% glutaraldehyde/4% PFA in PBT, 
washed, and prehybridized at 70ºC for 1 hr in Formamide, 5X SSC pH 4.5, 0.5% Tween-20, 
0.5µg/ml Heparin. Hybridization solution: 1/10 of probe reactions were added to 
prehybridization solution containing 10µg/ml herring sperm DNA, and 0.1% yeast tRNA, 
Embryos were hybridized overnight at 70ºC. Embryos were then extensively washed, 
incubated with 100µg/ml RNaseA for 30 mins, washed, blocked in 10% lamb serum in TBS-
T, and incubated with anti-Digoxigenin antibody overnight at 4ºC. Embryos were then 
extensively washed, incubated with substrate (BCIP, NBT) until signal to noise ratio was 
optimal. The reaction was stopped and embryos were post-fixed in 4% PFA/PBT, washed, 
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and images were captured. To section, embryos were dehydrated in a methanol series, treated 
with ethanol/xylenes/paraffin mixtures, embedded in paraffin, cut into 10µM sections and 
mounted on superfrost microscope slides. 
RNA isolation and Northern Blot analysis— Tissues of CD1 embryos and C57BL/6 
adult mice were homogenized and used to prepare total RNA using RNeasy mini kit 
(Qiagen). Northern blot analysis has been described previously75. A 400bp ASB4 probe was 
amplified using primers: F: 5’gagacacccctgcacacggcag, R: 5’ctcaggctgtgcagcaggacgc. The 
amplimer was TA cloned into pCR2.1 vector (invitrogen), amplified, and digested with 
EcoRI to liberate insert, which was then gel purified (Qiagen Gel Purification Kit), and used 
as a template for radioactive double-stranded random-primed probe synthesis (stratagene).  
Immunoprecipitation and immunoblot Analysis— Immunoprecipitation and 
immunoblot procedures have been described previously (reference). Unless otherwise noted, 
cells were lysed in protein buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1% Triton-X-100, 
1X Complete protease inhibitor cocktail (Roche)): 1mg of protein lysate was incubated with 
30ul of flag- or myc-conjugated beads O/N at 4ºC. Beads were washed four times with >20X 
volume lysis buffer, boiled in 30µl of 2X SDS loading buffer containing ME for 5 mins, 
and loaded on 10% protein gels. After electrophoresis, gels were transferred to PVDF 
membranes, and subjected to immunoblotting.  
Yeast 2-hybrid assay— Yeast 2-hybrid screens for ASB4 binding partners were 
performed using the Matchmaker 2-Hybrid system 2 (Clontech). Briefly, 
ASB4SOCS/GAL4 DNA binding domain (BD) fusion protein in pGBKT7 vector was 
transformed into AH109 yeast cells and selected for positive transformants on Trp-deficient 
agar. Positive transformants were amplified and mated with pretransformed 
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MATCHMAKER cDNA library-containing Y187 yeast (clontech) to produce co-
transformants. The screen described in this manuscript used a library isolated from adult 
human heart that was primed using an oligo dT primers (Clontech #HY4042AH). Mating 
mixtures were plated on agar plates lacking trp, leu, his, and ade for high stringency 
selection. The library vector was rescued from selected colonies, and identified by 
sequencing. To reconfirm interactions, both ASB4SOCS in pGBKT7 and resistant library 
constructs were co-transfected in various combinations with empty vectors as negative 
controls, and pGBKT7-p53/pGADT7-T vectors as positive interaction control. The prey 
clone representing human FIH contained a transcript encoding all but the 5 most N-terminal 
amino acids of FIH protein.  
Molecular Model Development— A fragment of mouse ASB4 spanning ankyrin 
repeats (ARs) 6-7 (V201 through A288) was used to query various fold recognition servers 
including FUGUE (http://tardis.nibio.go.jp/fugue/prfsearch.html), INUB 
(http://inub.cse.buffalo.edu/), and the successor to 3DPSSM, PHYRE 
(http://www.sbg.bio.ic.ac.uk/phyre/). Several ankyrin repeat containing protein crystal 
structures were identified as possessing similar folds to the mouse ASB4 fragment query. 
Homologous regions of 3 crystal structures were used as templates for model prediction. 
Model building was based on the ankyrin repeat domains from: 1) PYK2-associated protein 
beta (PDB ID 1DCQ), 2) Bcl-3 (PDB ID 1K1A) and the 3) Drosophila Notch receptor (PDB 
ID 1OT8). Models of the ASB4 ankyrin repeats were built, guided by the alignments 
returned from the fold-recognition servers, using the Modeler module of the InsightII 
molecular modeling system from Accelrys Inc. (www.accelrys.com).  
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Mass Spectrometry— Immunoprecipitates of flag-ASB4 infected COS7 cells were 
loaded on protein gels, stained with coomassie brilliant blue and the bands of interest were 
cut and processed according to the previously published protocols from the UNC/Duke 
Proteomic Center76. Peptide digests were analyzed on an ABI 4700 Proteomic Analyzer, 
MALDI-ToF/ToF (Applied Biosystems Inc., Foster City CA), and the identity of the protein 
was confirmed by searching the mass spectrometry results as outlined previously76.
Following protein identification, the peptide mixtures were re-spotted and the peptide, m/z 
1345.67, corresponding to the hydroxylated ASB4 peptide 1329.68, was analyzed by MS/MS 
along with the unhydroxylated peptide. For determination of peptide peak ratios, the curve 
areas of the 1329.68 and the 1345.66 peptide peaks relative to the curve area of the 1512.823 
peptide peak (shown by MS/MS in all samples to be derived from ASB4) were determined. 
C. RESULTS 
ASB4 is expressed in the vascular lineage during mouse embryonic development— In 
order to identify genes important during vascular development, we performed a set of 
experiments that compared the gene expression profiles of Flk1+ versus Flk1- cells isolated 
during different stages of differentiating embryonic stem (ES) cells.7 Out of 20,000 genes, 
ASB4 was the most highly differentially expressed gene in Flk1+ cells at early time points of 
differentiation (Fig. 2-1A). This differential expression was confirmed by RT-PCR analysis 
showing that ASB4 mRNA is highly enriched in the Flk1+ population at 84 h, 95 h, and 192 
h of differentiation, but is undetectable at 72 h of differentiation (before Flk1 is expressed in 
this system) (Fig. 2-1B). Since Flk1 is expressed in early precursor cells of the endothelial, 
hematopoietic, vascular smooth muscle, and cardiomyocyte lineages,77 we hypothesized that 
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ASB4 must be important during cardio- and/or hemato-vascular development. In support of 
this hypothesis, supervised hierarchical clustering analysis using only genes demonstrating 
O1.5 fold absolute Mean Fold Difference (MFD) in 84 h Flk1+ cells showed that ASB4 
clusters most closely with other genes known to be important in cardiovascular development 
including Flk1, Fibronectin, Gata2, and Gata4 (Fig. 2-1A). 
To confirm that ASB4 expression is high in anatomic locations known to harbor 
active vascular development and remodeling, and to further define exactly which tissue(s) 
ASB4 expression is confined to, we performed northern blots from embryonic and adult 
tissues. Global ASB4 mRNA expression was comparatively low in E7.5 embryos, but 
quickly increased until E9.5 (Fig. 2-2A). Highly vasculogenic tissues such as the allantois, 
yolk sac, and placenta all expressed high levels of ASB4. However, while ASB4 expression 
in the adult was highest in testis, ovary, and heart, it was undetectable in highly vascular 
organs such as lung, kidney, and liver (Fig. 2-2B), suggesting that ASB4 function may be 
critical to proper vascular development, but dispensable for maintenance of adult vessels in 
some tissues. Furthermore, tissues containing high numbers of hematopoietic cells such as 
spleen and bone marrow have undetectable levels of ASB4 mRNA expression.  
To further define the anatomic location of ASB4 expression during embryogenesis, 
we performed whole-mount in situ hybridization analysis using DIG-labeled ASB4 antisense 
riboprobes on mouse embryos of varying gestational stages. In E9.5 embryos, ASB4 is 
expressed in the intersomitic vessels, dorsal aorta, forelimb buds, allantois/umbilical vessels, 
vitelline vessels, septum transversum, proepicardium, capillary plexi of the head and 
branchial arches, endocardium, and the yolk sac vasculature (Fig. 2-3A,B,D,G,H). In E10.5 
embryos, areas of high ASB4 expression include the fore- and hind-limb buds, intersomitic 
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vessels, peripheral liver cells, and umbilical vessels (Fig. 2-3E,I). In E11.5 embryos, high 
levels of ASB4 expression are limited to the fore- and hind-limbs, and the most caudal (and 
most recently formed) intersomitic vessels (Fig. 2-3F). Analysis with sense probes confirmed 
the specificity of the antisense signal (Fig. 2-3C).  
The most striking recurring pattern of ASB4 embryonic expression is its high 
expression in primitive capillary plexi, followed by downregulation as vessels mature. At 
E9.5, ASB4 is highly expressed in the capillary plexi of the head and branchial arches (Fig. 
2-3B), but by E10.5 expression in these vascular beds is no longer detectable (Fig. 2-3E). 
Similarly, ASB4 expression is high in intersomitic vessels at E10.5, but by E11.5 is confined 
to only the most caudal (and thus recently formed) intersomitic vessels (Fig. 2-3F). This 
pattern is recapitulated in the placenta, with ASB4 expression decreasing between E9.5 and 
E.13.5. Finally, ASB4 expression is undetectable in highly vascularized adult organs such as 
kidney and lung. Taken together, these data indicate that ASB4 expression is high in the 
primitive vasculature during development, but is quickly downregulated in the mature 
vasculature. 
The SOCS box containing protein ASB4 assembles with a ubiquitin ligase complex— 
Since other SOCS box-containing proteins function as substrate adaptor proteins for Elongin 
B/Elongin C/Cullin/Roc ubiquitin ligase complexes by binding the complex in a SOCS box-
dependent manner, we investigated whether ASB4 exists in such complexes and can function 
as a ubiquitin ligase. In transient transfection assays using HEK-293T cells, flag-ASB4, but 
not empty vector (EV) or a mutant lacking the C-terminal SOCS box (SOCS) co-
precipitated Elongin B, Cul5, Roc1, and to a lesser extent Cul2 (Fig. 2-4A). Signal for co-
precipitating Cul2 was greatly increased using lysates from COS7 cells infected with flag-
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ASB4 adenovirus (Fig. 2-4B), indicating that ASB4 can utilize Cul2 or Cul5 complexes, and 
that this preference is highly dependent upon cellular context. Other ASBs have been shown 
to associate with Cul5/Roc1 and Cul5/Roc2 complexes, however Cul2 interactions in these 
reports were either not evaluated or evaluated only in HEK-293 cells.3, 78-80 Further studies 
will be needed to determine if the interaction of ASB4 with Cul2 is unique to ASB4 or 
inherent to all SOCS family members in the appropriate cellular context, and if ASB4 
function is affected by which Cullin complex is used. 
To evaluate whether ASB4 functions as part of a ubiquitin ligase complex, in vivo 
ubiquitination assays were performed. HEK-293T cells were transfected with flag-ASB4 for 
20hrs followed by treatment with the proteasome inhibitor MG-132 to allow polyubiquitin-
tagged protein accumulation. Flag-immunoprecipitates were then subjected to anti-flag and 
anti-ubiquitin (ub) immunoblotting. Strong ubiquitin immunoreactivity was detected in flag 
immunoprecipitates of flag-ASB4 transfected cells after MG-132 treatment (Fig. 2-4C, panel 
1). We reasoned that this signal could represent ubiquitinated ASB4-associated proteins, 
ubiquitinated ASB4 itself, or both. A 7kDa flag-immunoreactive laddering pattern was 
detected in flag-immunoprecipitates after treatment with MG-132, indicating that ASB4 itself 
is ubiquitinated (Fig. 2-4C, panel 2). Furthermore, flag-ASB4 co-precipitates with myc-
ASB4 in co-transfected HEK-293T cells, indicating that ASB4 complexes with itself (Fig. 2-
4D). Since additional co-IP experiments did not indicate that substrates are stably associated 
with ASB4 (data not shown), these data indicate that ASB4 is autoubiquitinated (which may 
represent a mechanism of self-regulation) and thus has intrinsic ubiquitin ligase activity 
similar to other SOCS proteins.  
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ASB4 binds to FIH through an EVNA motif— As a first step in the functional 
characterization of ASB4, we performed yeast 2-hybrid screens using an ASB4 mutant 
lacking the C-terminal SOCS box (ASB4SOCS) as bait. This mutant was utilized to avoid 
reconfirmation of known interactions with SOCS-box binding partners Elongin-B and 
Elongin-C. Using a human heart oligo-dT primed pretransformed yeast library, we screened 
over 1.5 x 107 independent clones and identified Factor Inhibiting HIF1 (FIH) as an 
interacting protein under stringent conditions (positive clones grew on plates lacking 
tryptophan, leucine, histidine, and adenine). The FIH prey clone encoded all but the 5 most 
N-terminal amino acids of the human FIH protein. This interaction was confirmed in a wheel 
assay in which yeast were transformed with various combinations of ASB4SOCS bait, FIH 
prey, empty vectors (V1, V2), or mismatched non-specific controls (Fig. 2-5A). p53 and T-
antigen (T) encoding plasmids were used as a positive control for an interaction in this 
system. Flag-immunoprecipitates of HEK-293T cells overexpressing flag-ASB4 but not flag-
ASB1 co-immunoprecipitated endogenous FIH, confirming the specificity of this interaction 
in mammalian cells (Fig. 2-5B). 
To determine which domain of ASB4 is necessary for FIH binding, a variety of N-
terminal flag-tagged mutants were generated that sequentially lack different domains of the 
ASB4 protein (Fig. 2-5C). Since the hydrophobic interactions between helices of adjacent 
ankyrin repeats are crucial for proper folding, we carefully positioned the borders of the 
deletions in order to best conserve the modular structure of the mutants. These mutants were 
transiently transfected into HEK-293T cells, flag immunoprecipitated, and immunoblotted 
with anti-FIH antibody to detect co-precipitating endogenous FIH protein (Fig. 2-5D). ASB4 
ARs 6 and 7 are necessary for interaction with FIH since mutants lacking either ARs 6 or 7 
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were unable to co-precipitate FIH. Mutants lacking other ARs (1,4,5,8-9) or the SOCS box 
were still able to co-precipitate FIH, indicating that these domains are dispensable for FIH 
binding and that deletion of single ARs does not disrupt the tertiary structure of the FIH-
interacting motif. 
FIH is an asparagine hydroxylase that is known to hydroxylate at least four proteins: 
HIF1, HIF2,81 I	B, and the NF-	B precursor protein p10582. FIH has been shown to 
bind to and hydroxylate each of these proteins on the -carbon of the asparagine residue that 
is found within leucine-flanked EVNA motifs, often in the context of ankyrin repeats (Fig. 2-
5E). (The residues surrounding asparagine are not totally conserved in all FIH-substrate 
peptides, but for simplicity will be referred to herein as EVNA motifs). The flanking leucines 
of FIH substrates bind first to position the EVNA motif for optimal binding in the FIH 
catalytic cleft via a process called “induced fit”.83 Since ASB4 contains a leucine-flanked 
EVNA motif in AR 6, we generated a number of point mutants in and around this motif to 
test their involvement in the FIH interaction. Each flag-tagged point mutant was transiently 
transfected with N-terminal myc-FIH, immunoprecipitated with anti-flag-conjugated agarose 
beads, and immunoblotted with myc-antibody to detect co-precipitating myc-FIH. Consistent 
with the “induced fit” model, point mutation of any of the flanking leucines to aspartate 
residues (L238D, L239D, L256D) reduced co-precipitating myc-FIH to undetectable levels 
(Fig. 2-5F). Single point mutants of the EVNA motif disrupted binding to varying extents. 
Mutation of the asparagine residue (N246A) reduced binding to undetectable levels, while 
mutation of the adjacent glutamate (E244A) or valine (V245T) residues reduced, but did not 
abolish binding. Mutation of the EVN residues to ATA abolished binding to undetectable 
levels. Taken together, these data indicate that ASB4 binds to FIH through a conserved 
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EVNA hydroxylation motif in AR 6, and suggest that ASB4 may be a novel FIH 
hydroxylation substrate. 
ASB4 is hydroxylated on asparagine 246 by an oxygen dependent mechanism—We 
initially hypothesized that the function of the ASB4-FIH interaction is to permit ASB4-
mediated FIH ubiquitination and subsequent degradation. However, despite various 
experimental approaches, we have not detected ASB4-dependent FIH ubiquitination or 
degradation (data not shown). Since FIH hydroxylates other proteins on asparagine residues 
within EVNA motifs, we considered the alternative hypothesis that the function of the ASB4-
FIH interaction may be to permit FIH-mediated ASB4 hydroxylation. To determine if the 
leucine-flanked EVNA motif is positioned in an appropriate conformation to allow binding to 
and hydroxylation by FIH, we generated a structural model of ASB4 ankyrin repeats 6 and 7 
(Fig. 2-6A). This model shows that the EVNA motif and flanking leucine residues of ASB4 
are optimally positioned to allow an “induced fit” of the EVNA motif into the catalytic cleft 
of FIH, and prompted further studies to examine the possibility of FIH-mediated ASB4 
hydroxylation. 
To test the hypothesis that ASB4 is an FIH hydroxylation substrate, adenovirally 
overexpressed flag-ASB4 was flag-immunoprecipitated from COS7 cells grown under 
normoxic culture conditions, in-gel trypsinized, and analyzed by matrix-assisted laser 
desorption time-of-flight (MALDI-TOF) mass spectrometry (MS). The predicted 
mass/charge ratio (m/z) of the EVNA-containing trypsin-digested peptide 
TLLDNNAEVNAR is 1329, and hydroxylation of this peptide is predicted to result in a 16 
Da shift to 1345. By MALDI-TOF analysis, we detected the 1329 Da peptide, and a 1345 Da 
peptide that did not match the predicted m/z value for any of the peptides from trypsin-
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digested flag-ASB4, suggesting that the m/z 1345 peak represents the hydroxylated form of 
the 1329 Da peptide (Fig. 2-6B). This was confirmed through MALDI-TOF-TOF (MS/MS) 
sequencing analysis of the 1329 and 1345 peptides, separately. Alignment of the MS/MS 
spectra of the unhydroxylated and hydroxylated peptides demonstrates that hydroxylation 
occurs only in peptides containing the asparagine residue of the EVNA motif, indicative of 
FIH-mediated asparagine hydroxylation of ASB4 (Fig. 2-6C).  
Under normoxic conditions, the ratio of unhydroxylated to hydroxylated ASB4 
peptide is 3:1, indicating that despite high oxygen concentrations, only 30% of ASB4 is 
hydroxylated (Fig. 2-6D). This is probably due to the supraphysiologic concentration of 
adenovirally-overexpressed ASB4 in this system, resulting in the saturation of endogenous 
FIH enzymatic activity. Further studies will be needed to determine the hydroxylation status 
of endogenous ASB4 in vivo during development. 
Since FIH-mediated hydroxylation is O2 dependent (and thus inhibited by hypoxia), 
we tested whether hypoxic conditions would decrease ASB4 hydroxylation. Importantly, 
when COS7 cells infected with flag-ASB4 adenovirus were treated with the chemical 
hypoxia mimetics dipyridyl (DP) and cobalt chloride (CoCl2), or the hydroxylase inhibitor 
dimethyloxaloylglycine (DMOG), only 10% of ASB4 EVNA-peptides were hydroxylated, 
indicative of decreased levels of ASB4 hydroxylation during hypoxia. Together, these data 
indicate that FIH binds directly to ASB4 in order to hydroxylate asparagine 246 via an 
oxygen-dependent mechanism, which suggests that ASB4 function may be regulated in an 
oxygen-dependent manner.  
ASB4 functions to promote ES cell differentiation into the vascular lineage via an 
oxygen-dependent mechanism— In order to investigate the biologic effects of ASB4, we 
39
overexpressed flag-ASB4 in a variety of cell types including both endothelial and non-
endothelial lineages. No overt effects on cell number or morphology were observed in these 
experiments (data not shown). We also attempted RNAi-mediated knockdown of ASB4 in 
endothelial cell lines using six different shRNA sequences from integrated lentivirus 
constructs, but were unable to attain greater than 50% silencing (data not shown), indicating 
that the ASB4 transcript may be inherently resistant to RNAi-mediated silencing. 
Because ASB4 is expressed in vascular stem cells during development, and other 
SOCS family proteins function to regulate cell differentiation, we investigated the effects of 
ASB4 overexpression on ES cell differentiation. Mouse ES cells were electroporated with 
linearized 3X-flag tagged ASB4 or p3Xflag-CMV empty vector (EV) and placed on G418 
selection to select for stable transfected clones. After 14 days, surviving colonies were picked 
and expanded, and expression was confirmed by immunoblotting (data not shown). Multiple 
clones were chosen for initial experiments to control for non-specific effects due to random 
integration. Upon differentiation, ASB4-expressing clones demonstrated a significant 
increase in Flk1+ cells at 96 h of differentiation compared to EV-clones (Fig. 2-7A-B), 
indicating that ASB4 expression leads to an expansion of the hematovascular lineage. To 
examine the causes of this Flk1+ cell increase, and to investigate the ramifications of this 
increase on downstream lineage commitment, real-time RT-PCR analysis was performed 
using stage- and lineage-restricted genes. Since Flk1+ cells arise from mesoderm cells during 
differentiation, we investigated the overall levels of Brachyury (T) expression as a marker for 
mesoderm. At 4d of differentiation, Brachyury levels were slightly, but significantly, 
increased in ASB4 expressing clones, suggesting increased mesodermal commitment (Fig. 2-
7C). Since Flk1+ cells are progenitors for both hematopoietic and vascular cells in this 
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system, we investigated the global expression levels of a variety of hematopoietic (Gata1, 
Scl/Tal) and vascular markers (Tie2, VE-Cadherin). All of these markers were tested at time 
points representing the peak of their expression during embryoid body (EB) differentiation 
(day 6 for hematopoietic markers, day 8 for vascular makers). Interestingly, when compared 
to EV clones, ASB4 expressing clones exhibited increased expression of vascular markers 
and decreased expression of hematopoietic markers, suggesting that forced expression of 
ASB4 causes preferential commitment of stem cells to the vascular lineage (Fig. 2-7C). 
Together, these data suggest that ASB4 induces the formation of hemangioblasts from 
mesodermal precursors and promotes hemangioblast commitment to the vascular lineage. 
As ASB4 is hydroxylated, and is thus likely to be regulated by oxygen concentration, 
we predicted that its effects on vascular lineage commitment are oxygen-dependent. To test 
this hypothesis, we differentiated the stably transfected ES cells described above under 
hypoxic conditions (1% atmospheric oxygen). Interestingly, the differences in the expression 
of hematopoietic and vascular lineage-specific markers observed with ASB4 overexpression 
under normoxic conditions were completely abrogated by hypoxic treatment (Fig. 2-7D). 
These results indicate that FIH-mediated hydroxylation of ASB4 under high oxygen 
concentrations is essential for ASB4’s ability to promote differentiation/maturation of the 
endothelial lineage. 
D. DISCUSSION 
In the present study, we show for the first time that ASB4 is a substrate recognition 
molecule of an E3 ubiquitin ligase complex, is highly expressed in the vascular lineage 
during development, is hydroxylated by FIH, and functions to promote differentiation and 
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maturation of the vascular lineage by an oxygen-dependent mechanism. These findings 
suggest that ASB4 functions in an oxygen-dependent manner in order to promote endothelial 
differentiation and/or maturation in response to increasing oxygen levels during early 
vascular development.  
ASB4 is a member of the SOCS superfamily and, like other family members, 
functions as the substrate-recognition molecule of a Cullin-based E3 ubiquitin ligase 
complex. The list of characterized E3 ubiquitin ligase proteins is rapidly expanding and 
recent studies have uncovered a novel role of ubiquitin ligases during endothelial 
differentiation and maturation. HIF and Notch family members are critical for proper 
vascular development, especially during endothelial remodeling, and both families are tightly 
regulated by ubiquitin-mediated proteasomal degradation. For example, von Hippel Lindau 
(VHL) protein binds to hydroxylated HIF to mediate its degradation in an oxygen-
dependent manner, while Fbw7, Numb, Itch, and Mind-bomb all modulate Notch 
signaling.84-92 Deficiencies of these factors result in vascular abnormalities, indicating that 
signal regulation via the ubiquitin-proteasome system is critical for proper vascular 
development.86, 93-95 The endothelial-restricted expression of ASB4 described in this report 
further emphasizes the important role of the ubiquitin-proteasome system in modulating 
endothelial biology during embryogenesis. 
The vascular expression of ASB4 is not only spatially restricted to the primitive 
endothelium, but is also tightly temporally regulated. ASB4 is maximally expressed in both 
the embryonic vasculature and the developing placenta from E9.5-10.5, but is then quickly 
downregulated, demonstrating that ASB4 function in the vasculature is temporally confined. 
Notably, this brief period of high ASB4 expression coincides with rapid and drastic changes 
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in embryonic blood oxygen levels. As the placenta forms between E9.5 to E10.5, oxygen 
delivery to the embryo quickly changes from passive diffusion through the multiple cell 
layers of the decidua and the embryo to maternal-fetal blood gas exchange across thin 
placental membranes. Intraembryonic oxygen tension quickly rises and the endothelium must 
transduce these environmental cues into an appropriate biologic response. ASB4 is uniquely 
expressed temporally and spatially to play a role in the response of the endothelium to 
changing oxygen concentrations. 
Our data indicate that one of the ramifications of ASB4 function is to increase the 
differentiation and maturation of the vascular lineage in an oxygen-dependent manner, 
suggesting that ASB4 may function to coordinate endothelial differentiation/maturation in 
the face of changing oxygen levels. This is especially intriguing considering the role of 
oxygen concentration on placental vascular development. The allantois, which has been 
shown to harbor mesoderm-derived vasculogenic cells,15 makes contact with the chorion 
around E8.5 to initiate placental vascularization (reviewed in 96, 97). During this process, a 
subset of trophoblast cells migrate into the uterine wall, proliferate, and differentiate into 
endothelial-like cytotrophoblast cells that line the maternal blood vessels to facilitate 
maternal-fetal blood-gas exchange. Oxygen tension is critical in this process. Early on, 
hypoxia activates cytotrophoblast proliferation and invasion into the uterine tissues, but as 
these cells reach the highly oxygenated maternal blood vessels, the high oxygen levels inhibit 
proliferation and promote their differentiation into an endothelial-like phenotype.98, 99 It is 
interesting to note that overall ASB4 expression levels in whole allantoides and placentas are 
initially high and decrease concomitantly with vessel maturation and increasing oxygen 
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tensions, suggesting that ASB4 functions to modulate placental cellular phenotypes in 
response to changing oxygen microenvironments. 
We identify that ASB4 is only the fourth in a limited list of known FIH hydroxylation 
substrates, and thus provide a mechanism for ASB4 modulation of cell phenotypes in an 
oxygen-dependent manner. FIH-mediated hydroxylation is known to be proportional to 
oxygen concentration, and in this way, ASB4 hydroxylation is the first step in the 
transduction of environmental oxygen cues to appropriate biological responses. Since we 
were unable to detect any differences in ASB4 expression, subcellular localization, or 
autoubiquitination under hypoxic conditions (data not shown), and since hydroxylation in 
other proteins has been shown to affect protein-protein interactions between the SOCS family 
member VHL and its ubiquitination substrate HIF, we predict that the functional 
ramification of ASB4 hydroxylation is to modulate ASB4 binding to and degradation of 
substrate protein(s). Until recently, the only known intracellular hydroxylated proteins were 
HIF subunits, and it was thus supposed that the cellular response to hypoxia was largely 
dependent upon HIF-mediated transcriptional upregulation of hypoxia response genes such 
as VEGF and GLUT-1.52 However, our data indicate that ASB4 is a member of a currently 
limited number of non-HIF FIH hydroxylation substrates and suggest that the mechanisms of 
the cellular hypoxic response may be much broader and more complex than initially 
suspected. 
We therefore propose that HIF subunits are responsible for the transcriptional 
response to hypoxia, while ASB4 may represent a major component of the cellular post-
translational response to changing oxygen levels. Compared to transcriptional upregulation, 
post-translational ubiquitination is much more rapid and enables a faster cellular response 
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without the lag-time associated with transcriptional activation and protein synthesis. For 
example, the ubiquitin-proteasome system extensively regulates the cell cycle, a situation in 
which rapid changes in protein levels are needed.100 Thus, oxygen-dependent ubiquitin ligase 
activity of ASB4 allows the cell to respond rapidly to the quickly changing oxygen 
microenvironments that are found immediately following the initiation of placental blood gas 
exchange. Furthermore, unlike HIF1, which is expressed in nearly all cell types, cell-
specific expression of hydroxylated proteins such as ASB4 allows cell type-specific 
responses to changing oxygen levels. In this case, ASB4 functions to initiate a rapid 
endothelial-differentiation in response to quickly rising oxygen tensions during development. 
These data provide new insights into the mechanistic complexity of oxygen-sensing in 
mammalian cells and suggest that endothelial and other cell types may mount unique 
responses to changing oxygen tensions during development through oxygen-dependent 
modulation of the ubiquitin-proteasome system.  
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Figure 2-1 ASB4 expression in ES cells.   
(A) Supervised hierarchical cluster of genes with O 1.5 fold absolute mean fold difference (MFD) in 84 h Flk1+ 
cells from embryoid bodies (EBs). The Flk1 cluster containing ASB4 is shown at right. This experiment is 
described in detail in Wang H. et al,7 and the complete data set is available online through the Gene Expression 
Omnibus (Series Record GSE3757, http://www.ncbi.nlm.nih.gov/geo) and through the University of North 
Carolina Microarray Database (http://genome.unc.edu).  
 
(B) RT-PCR analysis of ASB4 expression levels in Flk1+ cells from differentiated EBs. GAPDH is used as a 
loading control. US: unsorted. 
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Figure 2-2 ASB4 mRNA expression in embryonic/adult tissues. 
(A) Northern blot analysis of ASB4 expression levels in whole-embryos and dissected extra-embryonic tissues.  
 
(B) Northern blot analysis of ASB4 expression levels in adult tissues. BM: bone marrow. Ethidium bromide 
staining of 28s rRNA was used for loading control.  
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Figure 2-3 ASB4 Expression pattern during mouse embryogenesis. 
Whole mount in situ hybridization using DIG-labeled RNA probes for ASB4 was performed on mouse embryos 
between days 9.5 and 11.5 post-coitum. All images used antisense probes except (C) (sense probe). Purple 
staining denotes positive signal. In some cases (G, H, I), stained whole embryos were paraffin-embedded and 
sectioned for microscopic examination. (Cont’d on following page). 
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(A) E9.5 embryo. Arrow: allantois. Arrowhead: forelimb. Bar: 500 µm.  
 
(B) E9.5 embryo: high magnification. Arrow: rostral capillary plexus. Arrowheads: branchial arch capillary 
plexi. Bar: 50 µm.  
 
(C) E9.5 embryo probed with sense probe as a negative control. Bar: 500 µm.  
 
(D) E9.5 yolk sac. Arrows: yolk sac vessels. Bar: 750 µm.  
 
(E) E10.5 embryo. Arrow: umbilical vessels. Bar: 800 µm.  
 
(F) E11.5 embryo. Arrow: caudal intersomitic vessels. Bar: 1 mm.  
 
(G) E9.5 embryo section. Transverse section of heart. Arrow: endocardium. Arrow heads: dorsal aorta and 
intersomitic vessel. Bar: 80 µm.  
 
(H) E9.5 embryo section. Sagittal section of heart. v: ventricle. Arrow: pro-epicardium/septum transversum.  
 
(I) E10.5 embryo section. Transverse section of liver. HL: hindlimb. FL: forelimb. Arrow: liver. Arrowhead: 
umbilical vessels. Bar: 150 µm.  
 
(J) Schematic of section location in (G) and (I).  
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Figure 2-4 ASB4 associates with a ubiquitin ligase complex. 
(A) HEK-293T cells were transfected with flag-ASB4, flag-ASB4SOCS (flag-SOCS), or empty pCMV 
vector (EV). Lysates were immunoprecipitated with anti-flag agarose beads and subjected to immunoblotting 
with anti-flag, Cul2, Cul5, Elongin B, and Roc1 antibodies. Asterices denote non-specific bands.  
 
(B) COS7 cells were infected with flag-ASB4 adenovirus or GFP alone-adenovirus (GFP). Lysates were 
immunoprecipitated and immunoblotted as in (A).  
 
(C) HEK-293T cells were transfected with flag-ASB4, cultured for 20 hrs, and then treated with 40µM of the 
proteasome inhibitor MG-132 for 4 hrs before protein harvest. Lysates were immunoprecipitated as in (A) and 
immunoblotted with anti-Ubiquitin (ub) and anti-flag antibodies.  
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(D) HEK-293T cells were co-transfected with flag-ASB4 and myc-ASB4, immunoprecipitated with anti-myc 
agarose beads, and immunoblotted. 
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Figure 2-5 ASB4 binds to FIH through EVNA motif in ankyrin repeat #6 
(A) Yeast wheel assay. Yeast transformed with different combinations of bait (ASB4SOCS) and prey (FIH) 
constructs were spread on a high stringency selective plate lacking tryptophan, leucine, histidine, and adenine. 
p53 and T-antigen (T) were used as positive control. V1: empty bait vector (pGBKT7). V2: empty prey vector 
(pGADT7).  
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(B) HEK-293T cells were transfected with either flag-ASB4 or flag-ASB1. Lysates were immunoprecipitated 
with flag antibody-conjugated agarose beads and immunoblotted with anti-flag and anti-FIH antibodies.  
 
(C) Schematic of ASB4 with N-terminal variable region (NTV), 9 tandem ankyrin repeats (poorly conserved 
repeats are indicated by parentheses), and a C-terminal SOCS box. The EVNA motif is contained in the loop of 
ankyrin repeat #6. Schematics of N-terminal flag-tagged constructs are denoted below.  
 
(D) HEK-293T cells were transfected with flag-ASB4, flag-ASB1, and the flag-ASB4 deletion mutants 
described in (C). Protein lysates were immuoprecipitated with anti-flag agarose, and immunoblotted with anti-
FIH antibody.  
 
(E) Sequence alignment of mouse ASB4 and other known FIH hydroxylation substrates. Consensus sequence 
shows high conservation of EVNA motif and flanking leucine residues. Residue numbers are indicated above 
ASB4 sequence.  
 
(F) HEK-293T cells were transfected with various flag-ASB4 point mutants and myc-FIH. Lysates were 
immunoprecipitated with flag antibody-conjugated agarose beads and immunoblotted with anti-flag and anti-
myc antibodies. 
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Figure 2-6 ASB4 is hydroxylated on asparagine 246. 
(A) Structural model of ASB4 ARs 6-7 (yellow ribbon backbone) positioned above FIH (grey stick 
backbone)/HIF peptide (purple ribbon backbone) crystal structure (PDB ID 1H2K). Space filled EVNA residues 
are colored orange. Space filled FIH residues contributing to HIF binding are colored yellow. Leucines and 
other possible hydrophobic interacting residues are colored blue.  
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(B) COS7 cells were infected with flag-ASB4 adenovirus for 24 hours. Lysates were immunoprecipitated with 
flag antibody-conjugated agarose beads. Beads were eluted with flag-peptide and subjected to SDS-PAGE and 
coomassie staining. Flag-ASB4 bands were subjected to in-gel trypsin digest, and MALDI-TOF mass 
spectrometric analysis. The 1329 Da peak is the predicted molecular weight of the EVNA-motif containing 
peptide and the 1345 Da peak (asterisk) is the predicted molecular weight of the hydroxylated peptide.  
 
(C) The 1329 and 1345 Da peptides were analyzed by MS/MS. A 16 Da shift was observed with the y4-y8 ions, 
but not with y2 ions, consistent with hydroxylation at the asparagine residue.  
 
(D) COS7 cells infected with flag-ASB4 adenovirus were treated with various hypoxia mimetics/FIH inhibitors 
and flag-ASB4 protein was isolated and analyzed as in (B). The peak area ratio of unhydroxylated (1329 Da) to 
hydroxylated (1345 Da) peptide was compared after culturing cells in normoxia, 3hrs 100 µM dipyridyl (DP), 
24hrs 150 µM CoCl2, or 24 hrs 1mM dimethyloxalylglycine (DMOG). 
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Figure 2-7 ASB4 oxygen-dependent effect on vascular differentiation. 
ES cells were electroporated with constructs encoding CMV promoter-driven 3X-flag ASB4 or vector alone 
(empty vector, EV), and stably-expressing clones were selected for by culture in G418 for 14 days. Positive 
clones were isolated, expanded, and used for differentiation experiments as previously described.  
 
(A,B) FACS analysis of 96 h differentiated embryoid bodies (EBs) shows drastic increase in Flk1+ cells in 
ASB4-expressing clones. Results in (A) are representative of three independent experiments. Results in (B) 
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represent an average of three independent clones in three independent differentiation experiments. Flk1+ cells 
in ASB4-expressing clones were normalized to EV clones in each experiment.  
 
(C) Real-time RT-PCR analysis of differentiated EBs was used to determine the lineage commitment of Flk1+ 
cells. When compared with empty vector, ASB4 expressing ES cells show an increase in markers of mesoderm 
commitment (Brachyury (T)) and an increase in a hemangioblast marker (Flk1) at day 4 of differentiation, a 
decrease in hematopoietic lineage markers (Gata1, Scl/Tal) at day 6, and an increase in vascular markers (Tie2, 
VE-Cadherin) at day 8. Results represent averages of three independent biologic replicates.  
 
(D) EBs stably expressing either ASB4 or EV were differentiated in hypoxic conditions (1% oxygen) and 
analyzed via real-time PCR as described in (C). 
Chapter 3 ASB4-/- MOUSE GENERATION 
A. INTRODUCTION 
The generation of mice genetically engineered to lack specific genes (“knockout 
mice”) has become a standard method of evaluating the biologic function and significance of 
specific genes. Knockout mice have been particularly useful in identifying genes with crucial 
roles during vascular development since vascular defects often lead to severe phenotypes and 
embryonic lethality. The studies described in Chapter 2 establish ASB4 as an oxygen-
regulated SOCS-box E3 ubiquitin ligase that is highly expressed in the vasculature during 
development. Notably, mice lacking genes that are important in the cellular oxygen response 
(VHL, HIF1, and HIF2) die around E10 of development due to vascular defects.56, 58-60, 101, 
102 Since we have shown that ASB4 is involved in modulating the oxygen-response of the 
developing vasculature, we predicted that mice lacking ASB4 would die in utero due to 
vascular malformation. This chapter describes the production and very early stages of 
characterization of ASB4-/- mice. 
Traditionally, knockout mice have been generated by “knock-in” of reporter genes 
such as LacZ or eGFP which, following homologous recombination, replace (or “knockout”) 
one or more exons of the target gene. The presence of these reporter genes in the target gene 
locus allows for analysis of target gene expression in the generated mouse line, and also 
prevents transcriptional read-through of the locus due to the presence of strong 
transcriptional stop sites following the reporter gene sequences. However, if knockout mice 
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generated by this traditional approach are not viable (embryonic lethal), phenotypic 
characterization is limited to development, and adult characterization of the biologic role of 
the gene is impossible.  
To avoid this problem, mice can be generated that contain exon(s) of the target gene 
that are flanked by loxP sites (“floxed”). LoxP sites are recognized by cre recombinase, 
which excises all genetic material between LoxP site pairs. Mice with floxed target gene 
exons can then be mated with mice which ubiquitously express cre recombinase to generate 
knockout mice similar to the traditional method described above. Importantly, if these 
knockout mice are embryonic lethal, the floxed mice can be mated with conditionally 
expressing cre mice to result in inducible or tissue-specific knockout mice. Thus, if the 
knockout is embryonic lethal, this approach allows considerable flexibility in further 
phenotypic characterization. For example, if floxed mice are crossed with tamoxifen-
repressible promoter-driven cre, then pregnant mothers can be fed tamoxifen to repress cre,
preventing target gene excision and allowing normal development. After birth, floxed cre+
mice can be fed with tamoxifen until the point at which the role of the target gene is going to 
be evaluated. Discontinuation of tamoxifen releases the tamoxifen-repressible promoter, thus 
activating cre expression and resulting in inducible cre-mediated excision of the floxed 
alleles. Alternatively, if floxed mice are crossed with tissue-specific promoter driven cre,
then the cell-specific role of the target gene can be evaluated. Clearly, the conditional 
knockout approach has considerable advantages if (and only if) the phenotype is embryonic 
lethal. 
There are also disadvantages to the conditional knockout approach when compared to 
the traditional method. First, no reporter gene is knocked-in, so further expression analysis of 
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the target gene is impossible. Second, it requires additional cloning steps during knockout 
construct production, and additional downstream mouse crosses (including the availability of 
cre-expressing lines). Finally, the risk of generating a hypomorphic but not null allele is 
greater using this approach. This is due to: 1) the lack of a knocked-in gene with its strong 
transcriptional stop site, 2) the inherent limitation in how much genetic material can be 
deleted (<1 kb compared to <25 kb with the traditional approach), and 3) the resultant 
possibility of transcriptional read-through and translation of truncated mutant proteins (with 
unpredictable cellular effects). However, all of these possibilities can be ruled out by testing 
for the presence of endogenous target gene protein product with appropriate antibodies. Since 
our expression data of ASB4 during development was considerable, since we predicted that 
mice lacking ASB4 would die in utero, and since we are able to confirm the absence of 
ASB4 protein by immunoblot, we decided to evaluate the biologic function of ASB4 by the 
conditional approach described above.  
B. MATERIALS AND METHODS 
Southern Blot. 5’ external probe was amplified using the primers: SPF 
(cagttcccatccctgttcacattc), SPR (gagttaagggtgtccttgccagttc) and TA cloned into pCR2.1 topo 
vector (Invitrogen). Template for probe prep was excised using flanking EcoRI sites, and 
labeled with RT random Prime-It system (Stratagene) to produce cDNA labeled probe.  
PCR primers for amplification of homology arms from 129 ES cell genomic DNA: 
LAF (long arm forward) (ggtaccgaaagatgcgccaggggcacttcgatggtc), LAR 
(gcggccgcggtgctggaaggcctaccacatcacctgag), TAF (target arm forward) 
(gtcgacagtttaaaggacctgagaactcagggagag), TAR 
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(ggtaccataacttcgtataatgtatgctatacgaagttatagcctgaccgagaaccacactgtcacac), SAF 
(caattgtctggggctaagttcaggcaagcctctc), SAR (atcgattaagcgggtcccttccgctctacgtg), PCR primer 
sequences for genotyping: TKR1 (tctagaaagtataggaacttcggcgcgcc), CAF 
(caattgtgtgaaggggatcagatccatgtaattgt), flpF2 (agtcagactaagatactgcggctccagccaggc), flpR2 
(aagcggagcaatgatttatcaggagagcagc), LA5’R (gttcagcttttgttcctgcactg), TAFrc 
(tgagttctcaggtcctttaaactggag), cre1 (cctggaaaatgcttctgtccg), cre2 (cagggtgttataagcaatccc), 
chr11F (aacacacactggcaggactggctagg), chr11R (caatggtaggctcactctgggagatgata) 
Rabbits were injected with the mouse ASB4 peptide 244VNARDDDFKSPLHK to 
produce anti-ASB4 antibodies. Sera from these rabbits were immunopurified using the same 
peptide. 
C. RESULTS 
Since the conditional approach limits the amount of genetic material to be deleted to 
around 1 kb, we first needed to decide which exon(s) to flox. ASB4 is composed of 5 exons 
spanning 41 kb which are relatively evenly distributed, thus preventing the floxing of 
multiple exons. At the time of production, it was not known which domain was important for 
ASB4 protein function, so we decided to flox the first exon with the start codon and upstream 
putative transcriptional start sites (Fig. 3-1). ASB4 exon 1 is 197 bp long, and encodes the 
first 62 (out of 426) amino acids of the ASB4 protein. We also carefully placed the 5’ loxP 
site to prevent any disruption of ASB4 promoter structure to allow normal transcription from 
the ASB4flox locus. 
Genomic DNA of 129SvEv cells was used as a PCR template to generate the short, 
long, and target arms of homology. These arms were then subcloned into pAMC vector 
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(supplied by UNC Animal Models Core), which contains MC1 promoter-driven neomycin 
resistance gene between the arms of homology for positive selection, and PGK promoter-
driven diphtheria toxin gene outside the arms of homology for negative selection in 
randomly-integrated clones. This ASB4 knockout construct was then linearized and 
electroporated into ES cells from male 129SvEv mice for homologous recombination. Cells 
were grown in G418 (a potent neomycin analog) for 14 days, and resistant clones were 
picked and expanded. Floxed recombinants were confirmed by PCR using the primer pair 
CAF/TKR1, producing a 2 kb product in positive clones, and no product in negative clones 
(Fig. 3-2A). CAF primer binds outside the short arm of homology, and thus anchors this 
amplimer to the ASB4 locus and prevents amplification from random integration events. Out 
of 190 screened G418-resistant colonies, 5 were PCR-positive indicating a moderate rate of 
homologous recombination. PCR-positive recombinants were further confirmed using 
Southern blotting with a probe external to the arms of homology and HindIII digested tail 
DNA (Fig. 3-2B). Using this approach, the wild-type ASB4 locus shows a band of 5.7 kb 
while the targeted locus shows a band of 9.2 kb. All of the PCR-positive recombinants were 
reconfirmed using this approach. 
Positive recombinants were then electroporated with constructs expressing flp-
recombinase to excise the frt-flanked neomycin resistance cassette, since the neo gene in the 
ASB4 locus could have effects on ASB4 expression or general mouse development. 
Thymidine kinase (TK) is contained within the knockout construct in the neo cassette and 
allows for negative selection against non-flp-excised clones. TK integrates gancyclovir into 
the DNA of replicating cells, resulting in cell death. Thus, when flp-treated cells were grown 
in the presence of gancyclovir, only cells with flp-excised (“flipped”) TK/neo cassettes could 
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survive. Positive flipped clones were confirmed by PCR using the primer pair flpF2/flpR2 
(Fig. 3-2C). These primers both bind to the endogenous ASB4 locus, but flank ~100 bp of 
residual vector sequence (including one frt site and one loxP site) in the floxed allele. Thus, 
the ASB4 WT locus results in an amplimer of 390 bp, while ASB4flox locus results in an 
amplimer of 504 bp. Wild-type ES cells show one band of 390 bp, while targeted floxed 
ASB4 allele-containing cells (denoted ASB4flox/+) show one band of 390 bp (WT allele) and 
one band of 504 bp (floxed allele). This PCR reaction represents the genotyping strategy for 
ASB4flox mice.  
Next, ASB4flox/+ ES cells (129SvEv strain, male gender) were injected into C57BL/6 
blastocysts and implanted into pseudopregnant female mice to produce ASB4flox/+ chimeric 
mice (Fig. 3-3A). 24 male chimeras were produced which were then mated with WT 
C57BL/6 females to produce ASB4flox/+ heterozygote containing litters. Germline 
transmission varied from 0% to near 100% resulting in >50 ASB4flox/+ pups. (This ASB4flox/+ 
line will be propagated in case of embryonic lethality of ASB4-/- mice.) To excise the floxed 
ASB4 exon 1, ASB4flox/+ mice were crossed with C57BL/6 EIIa promoter-driven cre 
transgenic mice. EIIa promoter results in cre expression in all cell types beginning around the 
4-cell stage of the embryo.103 Thus, pups inheriting the cre allele will be predominantly 
ASB4+/-, but might contain some level of ASB4flox/+ chimerism. Cre-mediated excision of 
ASB4 exon 1 was confirmed by PCR using the primer set flpF2/LA5’R/TAFrc on tail clip 
genomic DNA (Fig. 3-3B). The flpF2/TAFrc primer pair results in amplimers of 234 bp only 
from the ASB4+ allele since TAFrc is present in the WT locus, but absent from the cre-
excised (ASB4- locus). The flpF2/LA5’R amplimer from the ASB4- locus is 390 bp, but this 
primer pair does not amplify from the ASB4+ locus under the cycling conditions used 
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(extension time too short). To pass the ASB4- allele through the germline (thus eliminating 
chimeric effects) and to cross-out the cre allele (cre has been shown to have developmental 
effects, thus confounding phenotypic analysis of mice lacking ASB4), these mice were 
crossed with WT C57BL/6 mice to produce true ASB4+/- heterozygotes. ASB4+/- cre- mice 
were confirmed by PCR using the primer mix described above and a cre primer mix (Fig. 3-
3B) (this PCR reaction represents the ASB4 knockout locus genotyping strategy).  
At the time of dissertation preparation, these ASB4+/- mice had recently reached 
sexual maturity and the first ASB4-/- containing litters were born. If the ASB4-/- genotype is 
not embryonic lethal, then litters from ASB4+/- intercrosses should show the normal 
Mendelian ratios of inheritance: 25% ASB4+/+, 50% ASB4+/-, 25% ASB4-/-. So far, out of 44 
pups from ASB4+/- intercrosses, 7 out of 44 have been ASB4-/- (16%), 19 out of 44 have been 
ASB4+/- (43%), and 18 out of 44 have been ASB4+/+ (41%) (Fig. 3-3C). While more litters 
will be needed to increase confidence in these ratios, these numbers indicate that some subset 
of ASB4-/- mice may die before genotyping (~14 days after birth) indicating that lack of 
ASB4 may result in an embryonic lethal phenotype with incomplete penetrance.  
To verify that the ASB4-/- mice were in fact “true” knockouts (i.e. did not exhibit 
transcriptional read-through and translation of truncated ASB4 protein), we tested for ASB4 
protein expression from testis lysates in one pair of ASB4-/- and ASB4+/+ male mice by 
western blot (Fig. 3-4). The antibody used was raised against an ASB4 peptide in exon 3, and 
should recognize a truncated protein (if present) in the ASB4-/- mice. This immunoblot shows 
that ASB4+/+, but not ASB4-/- mice show a single immunoreactive band in the appropriate 
molecular weight range for endogenous ASB4 (~48 kDa). No bands were identified of lower 
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molecular weight in the ASB4-/- lysates that might represent truncated protein products. These 
results indicate that ASB4-/- mice are indeed true “knockout” mice. 
D. DISCUSSION 
We describe here the successful production of mice with both an ASB4 conditional 
floxed allele, and an ASB4 null allele (ASB4 knockout mice). These mice will be an 
important tool for investigating the biological role of ASB4 in both embryonic development 
and adulthood.  
Given the high levels of ASB4 expression in the developing vasculature, and the 
functional role of ASB4 in endothelial differentiation, we predicted that mice lacking ASB4 
would die in utero due to vascular defects. Thus, the presence of any ASB4-/- mice from 
ASB4+/- intercrosses was surprising. However, the percentage of ASB4-/- mice in these litters 
is below the normal Mendelian ratio of 25%, suggesting that a subset of mice lacking ASB4 
is dying prior to birth. Given this incompletely penetrant phenotype, it will be important to 
backcross this line onto an inbred C57BL/6 strain and re-evaluate genotype percentages. 
Furthermore, timed pregnancies will be required to identify the gestational timing and causes 
of lethality in ASB4-/- mice. Given the high level of vascular expression of ASB4 around E9.5 
of development, I predict that a subset of ASB4-/- mice die around E10 due to vascular 
malformations and a subset of ASB4-/- mice survive due to so-far undefined compensatory 
mechanisms.  
If significant numbers of ASB4-/- survive until birth, vascular phenotypes can be 
evaluated in newborns and adults. A few questions can be addressed: Do ASB4-/- mice 
vascularize the retina in response to hyperoxic/hypoxic challenge? Do ASB4-/- mice 
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vascularize tumors comparable to wild-type mice? Do ASB4-/- mice revascularize ischemic 
tissue similar to wild-type mice? All of these experiments will be particularly interesting 
given the involvement of hypoxia in retinal and tumor angiogenesis, combined with ASB4’s 
role in modulating the cellular oxygen response. 
ASB4 is also highly expressed in the heart, testis, and ovaries of adult mice. 
Therefore, if ASB4-/- mice survive until adulthood, phenotypic characterization should 
include structural and functional analysis of these organs. Do ASB4-/- mice have larger or 
smaller heart walls/defective valves/septal defects/etc.? Do ASB4-/- mice have a normal 
cardiac hypertrophic response? Do ASB4-/- mice have fertility phenotypes? These analyses 
will need to be accompanied by further analysis of the cellular expression pattern of ASB4 in 
these tissues (either by in situ hybridization or immunhistochemistry), but will be crucial to 
uncover novel biological roles of ASB4.  
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Figure 3-1 ASB4 knockout schematic 
The ASB4 knockout construct was PCR-cloned from R1 mouse ES cell genomic DNA and contains a 2 kb short 
arm of homology, a 0.8 kb target arm that includes exon 1 flanked by loxP sites (“floxed”) and thus susceptible 
to cre recombinase-mediated excision, and a 8 kb long arm of homology. The construct also includes a 
diphtheria toxin gene outside the homology arms to negatively select for random-insertion events, and an 
internal neomycin resistence gene for positive selection. ES cells were electroporated with linearized knockout 
construct and cultured in G418 (neomycin analog) for 14 days. G418 resistant clones were expanded and 
homologous recombination at the ASB4 locus was confirmed by PCR with CAF/TKR1 primers, and HindIII 
digested Southern blot using the denoted probe. Positive clones were then electroporated with flp recombinase 
expressing vector to excise the frt-flanked neomycin resistance cassette. Thymidine kinase in the original 
knockout construct kills cells in the presence of gancyclovir, and so provided negative selection for flp activity. 
Cells were grown in gancyclovir for 14 days, and surviving clones were expanded. “Flipped” clones were 
confirmed by PCR with flpF2/flpR2 primers. This locus is referred to as ASB4flox. Cells containing this locus 
were used to generate ASB4flox/+ mice, which were then crossed with cre-expressing mice to generate mice 
lacking exon 1 (ASB4+/- mice). Cre-excision was confirmed by PCR with flpF2/LA5’R primers (combined with 
flpF2/TAFrc primers as a PCR positive control. E1: Exon 1 (red squares), Frt: Flp recombinase recognitions 
sites (yellow triangles), loxP: cre recombinase recognitions sites (green triangles), H: HindIII restriction enzyme 
sites, probe: external southern probe binding site, PGK-TK: PGK promoter-driven thymidine kinase gene (blue 
squares), MC1neo: MC1 promoter-driven neomycin resistance gene (blue squares), PGK-DT: PGK promoter-
driven diphtheria toxin gene (blue squares). PCR primer names:CAF, flpF2, flpR2, TAFrc, TKR1, LA5’R.  
67
Figure 3-2 Confirmation of ASB4 locus manipulations in ES cells. 
ES cells were electroporated with linearized ASB4 knockout construct (see fig. 3-1) and selected with G418 for 
14 days.  
 
(A) Lysates were used as a template for PCR using the primers CAF/TKR1 (see Fig. 3-1) to identify positive 
clones for a targeted ASB4 locus. (+) denotes PCR positive control. (*) denotes clone that was grown for 
downstream manipulations.  
 
(B) Southern Blot using HindIII digested ES cell genomic DNA, and an external probe (as shown in Fig. 3-1) 
was performed on PCR positive clones. Wild-type locus showed a band of 5.7 kb, while the targeted locus 
showed a band of 9.2 kb (due to addition of neo/TK cassette).  
 
(C) Targeted ES cells were treated with flp recombinase to excise the neo/TK cassette and grown in gancyclovir 
for 14 days to select against non-excised clones. Lysates were prepared and used as a template for PCR using 
flpF2/flpR2 primer pair (see Fig. 3-1). Amplification from the wild-type allele results in a 390 bp band while 
amplification from the “floxed” allele results in a 504 bp band. (*) denotes clone used for blastocyst injections. 
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Figure 3-3 ASB4 knockout breeding diagram 
Chimeric mice containing both 129-derived ASB4flox/+ cells and C57BL/6-derived ASB4+/+ cells were crossed 
with C57BL/6 ASB4+/+ mice. Agouti pups contained 129-derived DNA, and half of these inherited the ASB4flox 
allele. ASB4flox/+ pups were confirmed by PCR with flpF2/flpR2 primers (see Fig. 3-1). ASB4flox/+ mice were 
then crossed with transgenic mice expressing cre-recombinase in all tissues (ubiquitous cre mice) to produce 
ASB4+/- cre+ pups (confirmed by PCR with flpF2/TAFrc/LA5’R primers (see Fig. 3-1)). In order to cross out 
cre-recombinase, and to pass the ASB4- allele through the germline, these mice were crossed with ASB4+/+ mice 
to result in true ASB4+/- heterozygotes (confirmed by PCR in inset B with primer pairs in parentheses (see Fig. 
3-1)). These mice were interbred to generate ASB4-/- containing litters (genotyping shown in inset C (see Fig. 3-
1)). If ASB4-/- mice are not viable, ASB4flox/+ mice will be crossed with conditional-promoter driven cre mice to 
further evaluate timing and tissue-specific ramifications of ASB4-/- phenotype. 
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Figure 3-4 Immunoblot confirmation of ASB4 -/- genotype. 
Protein lysates from whole testis from 2 month old male littermates were used to evaluate whether ASB4 
protein is absent from ASB4-/- mice. A non-specific band is shown as a loading control.
Chapter 4 GENERAL DISCUSSION 
A. ASB4 MOLECULAR FUNCTION 
The experiments described herein attempt to fully characterize the role of ASB4 
during vascular development by uncovering its expression, molecular function, biologic 
consequences, and molecular regulation. Data generated here reveal that 1) ASB4 expression 
is largely restricted to the vasculature during a narrow time window during development, 2) 
ASB4 binds to ubiquitination machinery and is associated with ubiquitination activity, 3) 
ASB4 promotes the differentiation of the vascular lineage, and 4) ASB4 is a hydroxylation 
substrate of FIH and is thus regulated by oxygen concentration (Chapter 2). 
Like all E3 ubiquitin ligase proteins, the functional ramifications of ASB4 are 
dependent upon the function of the substrate protein(s) which it degrades (Fig. 4-1). Multiple 
attempts to identify binding partners of ASB4 have so far not yielded the identification of 
ASB4 ubiquitination substrate proteins. Yeast 2-hybrid screens were performed using 
libraries generated from E11.5 mouse embryo and adult human heart mRNA and over 12 
million independent clones were screened overall. (The yeast 2-hybrid approach was used 
successfully in the identification of APS as an ASB6 substrate).4 Using the embryo library a 
specific interaction with a protein called SET was identified, but this interaction could not be 
confirmed by co-IP in mammalian cells despite multiple attempts and approaches (data not 
shown). The screen using adult human heart library yielded the potential interacting protein 
FIH (one clone!) which was subsequently confirmed and functionally characterized in 
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mammalian cells (Chapter 2). This indicates that the yeast 2-hybrid approach can be used to 
identify binding partners of ASB4, but the fact that FIH was only represented by a single 
clone suggests that the sensitivity of this approach is low.  
As an alternative approach, mammalian cells were transfected with flag-ASB4, flag-
immunoprecipitated, and analyzed by coomassie staining of SDS-PAGE gels to identify co-
purifying protein bands. (This approach was used successfully by other groups to identify 
ASB-9 binding partners).3 Positive bands were then cut out and submitted for sequencing by 
mass spectrometry. Furthermore, ASB4SOCS was used in these experiments to 
theoretically stabilize substrate proteins by a dominant negative mechanism. This 
experimental approach was performed using a variety of cell types that do and don’t express 
ASB4 including HEK-293, COS7, HUVEC, EPCs, and rat neonatal cardiomyocytes. Specific 
bands were co-purified, but after sequencing they were eliminated as potential ASB4 
substrates due to 1) known function of the proteins that did not match the known properties 
of ASB4, or 2) co-purification with other non-related flag-tagged proteins in other co-IP 
screens. Many of these proteins were chaperones or other proteins of high abundance and 
promiscuous binding potential (tubulins, myosins, dnaJ chaperones). Notably, despite many 
rounds of optimization, true interactors such as Elongin-B, Elongin-C, and FIH have not been 
visualized by coomassie stain, indicating that the sensitivity of the system for identifying 
binding partners under current conditions might be too low.  
Major caveats exist with both of these approaches. First, yeast-2 hybrid libraries and 
cell lines used for overexpression must express substrate for these approaches to be fruitful. 
However, it is impossible to predict where substrate is expressed at high levels. As a first best 
guess, libraries and cell lines that harbor ASB4 expression were utilized since ASB4 
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substrate is most likely to be expressed where ASB4 is expressed. Second, low-abundance 
proteins are difficult to detect using these methods. If ASB4 substrate is expressed at low 
levels (either at transcript or protein level), then sensitivity using these approaches may not 
be high enough to detect an interaction.  
The yeast 2-hybrid libraries that were used were generated commercially by an oligo-
dT priming method. The advantage of this approach is the ability to directionally clone into 
prey vectors, but this approach by definition includes entire 3’ untranslated regions (UTR) in 
prey constructs that don’t encode proteins. Since the average cDNA size in the libraries was 
1.9 kb (range: 0.4 - 3.8 kb) and the average 3’ UTR is ~1 kb (depending on tissue source), 
almost half of the information in the cDNAs isn’t translated into protein. In fact, the majority 
of positive clones in the screens turned out to be composed completely of 3’ UTR sequence. 
Therefore, nearly all of the cDNAs in this library contain short stretches of C-terminal 
protein-encoding sequence followed by long 3’ UTRs. Long stretches of protein-encoding 
regions are needed to preserve tertiary structure of potential interacting proteins. 
Interestingly, the FIH clone that was identified was quite long (>3kb) and encoded nearly the 
entire FIH protein. Because FIH folds in a jelly-roll manner, it can’t be broken up into 
domains that retain secondary structure and thus requires the entirety of the coding sequence 
for proper folding and binding potential. This most likely explains why only 1 clone of FIH 
was identified out of 12 million screened clones despite relatively high and ubiquitous levels 
of FIH mRNA expression. This might also explain why I have not been able to identify co-
purifying substrate proteins using this approach. As an alternative option, libraries generated 
using random primers can provide greater representation of N-terminal coding sequences, 
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although the ability to directionally clone would be lost and therefore half of all clones would 
be inserted in the antisense direction.   
Further optimization using the mass-spec approach and more sophisticated 
biochemical manipulations (such as proteasome inhibition and anti-ubiquitination 
purification) are now underway in a last-ditch effort to identify ASB4 substrate. Several 
technical options could increase the sensitivity of this approach. 3x-flag tagged ASB4 could 
be used to increase the capture of bait protein. Silver stain could be used to increase the 
sensitivity of in-gel detection, although this approach also presents technical difficulties for 
downstream mass spectrometric analysis. Finally, lysates from difficult-to-transfect cell lines 
(HUVEC) could be flowed-over purified bead-bound protein produced from easily 
transfectable cells (HEK-293).  
Identification of ubiquitin E3 ligase substrate proteins is a challenging endeavor since 
such interactions are often transient and result in destabilization of substrate protein. 
However, identification of substrate proteins for ASB4 will be an essential part of elucidating 
the biologic role of ASB4 during vascular development. 
B. ASB4 AS A COMPONENT OF THE OXYGEN SENSING SYSTEM 
The recent identification of the hydroxylase enzymes FIH and PHDs, whose activity 
is directly dependent on oxygen concentrations, provides a mechanism by which mammalian 
cells “sense” oxygen levels and transduce this environmental cue into an appropriate biologic 
response. However, until recently, the only known substrates of these hydroxylases, and 
indeed the only known intracellular hydroxylated proteins, were HIF transcription factors 
(Fig. 4-2). Thus, it was presumed that the hypoxic response was largely dependent on HIF-
74
mediated transcriptional upregulation of hypoxia response genes.  
The identification of ASB4 as a non-HIF FIH substrate implies that the cellular 
response to changing oxygen levels is more mechanistically complex than initially thought, 
and involves both transcriptional and post-translational responses. Furthermore, the cell-
specific expression of ASB4 suggests that the hypoxic response may differ among tissues, 
and this expression may provide insight into the endothelial-specific response to changing 
oxygen tensions during development.  
How exactly hydroxylation of ASB4 affects its function at the molecular level is, at 
this point, not clear. Given that we have not observed any change in ASB4 expression, 
ubiquitination, or subcellular localization in response to hypoxia, we hypothesize that, similar 
to VHL, ASB4 binds to its substrate in a manner determined by oxygen concentration, and in 
this case, degrades substrate when hydroxylated under high oxygen conditions. Identification 
of substrate protein(s) (described above) will be necessary to test this hypothesis.  
More generally, the identification of the leucine-flanked EVNA motif in the context 
of ankyrin repeats as a consensus hydroxylation site opens the door for the identification of 
many more FIH hydroxylation substrates. Ankyrin repeats are among the most common 
structural protein domains in all of nature and are present in a great diversity of proteins 
including secreted growth factors, receptors, transcription factors, scaffolding proteins, 
enzymes, etc. Furthermore, the leucine flanked EVNA motif is not rare among ankyrin 
repeats. For example, of 18 ASB family members, 14 contain motifs conserved enough to 
warrant further investigation (ASB1, ASB2, ASB3, ASB4, ASB5, ASB6, ASB8, ASB9, 
ASB11, ASB13, ASB14, ASB15, ASB16, ASB17), raising the possibility that hydroxylation 
of EVNA motifs specifically, and protein hydroxylation more generally, might be quite 
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common. In addition, Notch1, a protein shown to be involved in the hypoxic response, 
contains an EVNA motif within one of the ankyrin repeats that provide binding sites for 
transcriptional complex binding partners, perhaps providing a mechanism for the oxygen 
dependent activity of Notch1.104-106 Investigating the tissue expression and functional 
ramifications of these hydroxylation events will be crucial to our understanding of the 
cellular oxygen response. 
C. ASB4 BIOLOGIC FUNCTION 
ASB4 is expressed in the developing endothelium during a time in which the 
vasculature is exposed to dynamic changes in environmental cues and undergoes drastic 
morphologic changes. For example, blood flow is initiated which exerts shear and 
mechanical stresses on the vasculature, and maternal-fetal blood-gas exchange in the placenta 
is initiated which drastically changes embryonic oxygen tension from hypoxia to relative 
normoxia. Furthermore, the vasculature undergoes extensive morphologic changes during 
this time including arterial-venous specification, capillary plexus remodeling, and vessel 
maturation. Links between these environmental cues and morphologic changes are just 
beginning to be identified, and ASB4 is spatio-temporally expressed and regulated in such a 
way as to represent a potential direct link between oxygen cues and vascular morphologic 
responses.  
The data presented in Chapter 2 suggest that ASB4 promotes differentiation into the 
vascular lineage, but do not rule out the possibility that ASB4 may determine arterial-venous 
fate decisions in the developing vasculature. For example, ES cells overexpressing ASB4 
show increased levels some vascular markers (Tie2 and VE-cadherin) but not others 
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(PECAM) following differentiation, suggesting that Tie2 and VE-cadherin may be markers 
for some subset of endothelium. Indeed, Tie2 has been shown to be highly restricted to 
venous endothelium in avians, although this pattern has not been described in mammals.107, 
108 In this light, it is intriguing to speculate that ASB4 may function to transduce an oxygen-
signal to only well-perfused endothelium in order to specify an arterial fate to this subset of 
vessels. Alternatively, given that hypoxia is a potent activator of angiogenesis during 
adulthood, and that the endothelium reacts in a unique way to hypoxia (see Chapter 1), 
perhaps ASB4 functions to prevent disorganized vascular development in the global hypoxic 
environment of the early embryo. Or, perhaps ASB4 hydroxylation serves as an endothelial-
specific signal to initiate a transition from an early-developmental phenotype, to a mature 
phenotype as blood oxygenation is initiated. The embryoid body system described in Chapter 
2 could be used to evaluate further the effects of ASB4 on arterial-venous specification. 
ASB4-/- ES cells could be generated and used in these differentiation experiments (compared 
to ASB4+/- or WT cells) to determine if ASB4 serves as a genetic cue for arterial-venous 
specification. In these experiments, cells with or without ASB4 could be differentiated for 
four days with or without hypoxia, and sorted for flk1+ cells. These flk1+ cells could then be 
replated and further differentiated (with or without hypoxia) to analyze the relative 
expression patterns of arterial/venous markers (both by global and cell-specific experimental 
approaches). Furthermore, careful characterization of the vascular phenotype of ASB4-/- mice 
discussed in Chapter 3 should help elucidate the biologic role of ASB4 in the developing 
vasculature. 
This dissertation so far has focused on the endothelial-specific functions of ASB4 
both in the embryonic and placental vasculatures. However, ASB4 is expressed in other cell 
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types in the embryo and the adult that may contribute further evidence that ASB4 functions 
as an oxygen sensor for modulating differentiation. ASB4 expression in the testis is high in 
the spermatogenic lineage, and increases nearly two fold as type A spermatogonia 
differentiate into round spermatids (http://mrg.genetics.washington.edu/)109. It has been 
suggested that an oxygen gradient exists across the seminiferous tubule axis and serves as a 
signal to induce differentiation of sperm cells as they near the tubule lumen. Cells of the 
spermatogenic lineage are known to utilize highly anaerobic and glycolytic metabolism via 
the expression of a set of testes-specific glycolytic gene variants. Recently, a testes-specific 
HIF1 isoform, termed hHIF1Te was identified and shown to function as a dominant 
negative to wild-type HIF1.110 Expression of this variant along with other genes shown to 
inhibit HIF activity,112, 113 could downregulate HIF1 activity and the concomitant 
expression of the wild-type variants of glycolytic enzymes in order to allow the expression of 
testes-specific variants. Cells of the spermatogenic lineage clearly have a unique hypoxic 
response. Perhaps ASB4 functions to transduce the oxygen gradient signal into a 
differentiation signal to coordinate proper spermatogenic differentiation within the axis of the 
seminiferous tubule. 
While it remains a distinct possibility that ASB4 could ubiquitinate different substrate 
proteins in different tissues based on substrate tissue expression patterns, it is intriguing to 
speculate that the single biologic activity of ASB4 could be to promote oxygen-dependent 
differentiation of multiple cell types in multiple tissues due to the degradation of a single 
unifying anti-differentiation substrate protein. Further analysis of the ASB4-/- phenotypes 
combined with identification of substrate proteins will be critical in the further elucidation of 
ASB4 function. 
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Figure 4-1 Model of ASB4 function.  
ASB4 degradation of unknown substrate (denoted “??”) occurs only when ASB4 is hydroxylated in a high 
oxygen environment. Based on ES cell differentiation studies, we hypothesize that this substrate must have anti-
differentiation function. So, overexpression of ASB4 under normoxic conditions results in a pro-differentiation 
phenotype. 
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Figure 4-2 ASB4 represents a novel post-translational cellular oxygen response. 
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